th Friday April 17 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
16:00 - 17:30 h.
16:00 – 17:30 Debate Forum - DF01 Auditorium A DUAL DISORDERS IN SCIENTIFIC JOURNALS Track: Training in Dual Chair: Diagnosis Pedro Ruiz, Department of Psychiatry & Behavioral Sciences, Miller School of Medicine – University of Miami. FL, USA. Speakers: JOURNAL ADDICTION Robert West, Health Behavior Research, Department of Epidemiology, University College London, United Kingdom. JOURNAL OF DUAL DIAGNOSIS Alan Green, Department of Psychiatry, Dartmouth Medical School. NH, USA. REVISTA DE PATOLOGÍA DUAL Francisco J. Álvarez, Instituto de Estudios de Alcohol y Drogas, Universidad de Valladolid, España. EUROPEAN ADDICTION RESEARCH Wim van den Brink, University of Amsterdam/Amsterdam Institute for Addiction, The Netherlands. ACTAS ESPAÑOLAS DE PSIQUIATRÍA Miquel Roca, Universidad de las Islas Baleares. Mallorca, España. HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS Icro Maremmani, University of Pisa, University of Siena, Santa Chiara University Hospital, Pisa, Italy. ADVANCES ON DUAL DIAGNOSIS Gail Gilchrist, King's College London, United Kingdom.
16:00 – 17:30 Symposium – SY01 Auditorium B TREATMENT OF DUAL DISORDERS IN ADOLESCENTS AND YOUNG ADULTS WITH Track: PSYCHOTHERAPY BASED ON NEUROPSYCHE PHYSIOLOGY AT HUMAN BIRTH Psychotherapeutic Chair: Treatment in Dual Daniela Polese, University "Federico II" of Naples, Italy. Disorders Speakers: THE POSSIBILITY OF TREATING DUAL DISORDERS IN YOUNG POPULATION THROUGH PSYCHOTHERAPY BASED ON NEUROPSYCHE PHYSIOLOGY AT HUMAN BIRTH Daniela Polese, University "Federico II" of Naples, Italy. SEVERE MENTAL ILLNESSES, DUAL DIAGNOSIS AND VIOLENCE: A PSYCHOTHERAPEUTIC PROSPECTIVE FOR FORENSIC PSYCHIATRY Niccolò Trevisan, Italian Society of Criminology, Italy. PSYCHOTHERAPY PRACTICE OF DUAL PSYCHOPATHOLOGY IN YOUNG IN A COOPERATIVE SERVICE OF MEDICAL PSYCHOTHERAPY Piera Galeandro, Cooperativa Sociale di Psicoterapia Medica, Italy. PRELIMINARY DATA FROM AN EARLY DETECTION STUDY CONDUCTED IN CHILD AND ADOLESCENT COMMUNITY CENTERS Paolo Fiori, "Sapienza" Università di Roma, Italy.
16:00 – 17:30 Symposium – SY02 Room 1 IS EMOTIONAL DEPENDENCE A BEHAVIORAL ADDICTION WITHIN DUAL DISORDERS? Track: Behavioral Chair: addictions / Rosa Fernández-Marcote, UCA de Toledo. Hospital Provincial. SESCAM. Toledo, España.
www.cipd2015.com Pág. 1
th Friday April 17 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Gambling Disorders Speakers: FRAMEWORK OF EMOTIONAL BEHAVIORAL ADDICTION UNIT AND WITHIN THE RANGE OF DUAL DIAGNOSIS Mª Nieves Gómez, Ayuntamiento San Sebastian de los Reyes, Madrid, España. EMOTIONAL DEPENDENCY IN DAILY PRACTICES OF FAMILY PHYSICIANS: INTERVENTION AND BIOLOGISTIC BASIS Juan A. López, Hospital 12 de Octubre, CS Las Calesas, Madrid, España. TRANSVERSAL EMOTIONAL DEPENDENCY TREATMENT IN A THERAPEUTIC COMMUNITY FOR DUAL PATIENTS Lucas García, CTD El Alba. JCCM Castilla la Mancha, España.
16:00 – 17:30 Symposium - SY03 Room 2-3 BIOMARKERS IN DUAL DISORDERS Track: Multidisciplinary Chair: Intervention in Dual Magi Farré, Institut Hospital del Mar d'Investigacions Mèdiques-IMIM, Universitat Autònoma Disorders de Barcelona, España. Speakers: BIOMARKERS IN PSYCHIATRY: AN OVERVIEW Rocío Martín-Santos, Institute of Neurosciences, Hospital Clínic, IDIBAPS, CIBERSM, España. ARE CYTOKINES BIOLOGICAL MARKERS OF DUAL DIAGNOSIS? Fernando Rodriguez de Fonseca, Instituto IBIMA, Hospital Carlos Haya de Málaga, España. NEW BIOINFORMATIC TOOL FOR SUPPORTING BIOMARKERS IDENTIFICATION FOR PSYCHIATRIC DISORDERS: PSYGENET Laura Furlong, Institut Hospital del Mar d'Investigacions Mèdiques. Barcelona, España.
16:00 – 17:30 Symposium - SY04 Room 4 DUAL DISORDERS IN KETAMINE ADDICTION Track: Depression Chair: Wai Kwong Tang, The Chinese University of Hong Kong, China. Speakers: PSYCHIATRIC MORBIDITY IN KETAMINE USERS Wai Kwong Tang, The Chinese University of Hong Kong, China. THE DIFFERENTIAL ROLES OF PSYCHOSOCIAL RISKS BETWEEN KETAMINE USERS AND BETEL BUT CHEWERS IN TAIWAN Kun-Hua Lee, Kaohsiung Medical University, China.
16:00 – 17:30 Symposium - SY05 Room 5 BIPOLARITY AND ADDICTIVE DISORDERS Track: Bipolar Disorders Chair: Enrique Galli, Universidad Peruana Cayetano Heredia. Lima, Perú. Speakers: BIPOLARITY AND COCAINE TO THE BRAIN SPECT Agata Salazar, Universidad Peruana Cayetano Heredia. Lima, Perú. PREVALENCE AND BIPOLAR CLINIC Carlos Ordoñez, Hospital Hermilio Valdizan. Lima, Perú. DUAL DIAGNOSIS NEUROTOXIC THEORY Enrique Galli, Universidad Peruana Cayetano Heredia. Lima, Perú.
www.cipd2015.com Pág. 2
th Friday April 17 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
16:00 – 17:30 Symposium - SY06 Room 6 COGNITIVE NEUROSCIENCE APPLIED TO PERSONALITY DISORDERS AND PSYCHOPATHY Track: Personality Chair: Disorders Guillermo N. Jemar, Hospital Borda, Asociación Neuropsiquiátrica Argentina, Argentina. Speakers: NEUROBIOLOGY OF ANTISOCIAL BEHAVIOR AND NEUROBIOLOGICAL APPROACHES TO PSYCHOPATHOLOGY Martin Mazzoglio y Nabar, Asociación Neuropsiquiátrica Argentina - Servicio Penitenciario Federal Argentina, Argentina. THE ETHICAL AND LEGAL ASPECTS IN PERSONALITY DISORDERS AND PSYCHOPATHY Ramiro Isla, Asociación Neuropsiquiátrica Argentina - Defensoría General de La Nación, Argentina.
16:00 – 17:30 Symposium - SY07 Room 7 LATEST DEVELOPMENTS IN SIMULTANEOUS TREATMENT OF TRAUMA AND ADDICTION Track: Post-Traumatic Chair: Stress Ayna Johansen, Norwegian Centre for Addiction Research, University of Oslo, Norway. Speakers: CONCURRENT TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND ALCOHOL DEPENDENCE IN WOMEN IN A SWEDISH SETTING - A PILOT STUDY Anna Persson, Karolinska Institutet. Solna, Sweden. A RATIONALE FOR EMOTION-FOCUSED TREATMENT FOR COMORBID SUBSTANCE USE DISORDER AND POST-TRAUMATIC STRESS Shedeh Tavakoli, Northeastern Illinois University, Chicago. IL, USA. THERAPIST EXPERIENCES AND TRAINING NEEDS FOR TREATING SIMULTANEOUS TRAUMA AND ADDICTION Ingerid E. Bjelland, Frogn Kommune, Norway.
16:00 – 16:45 Main Lecture - ML01 Room 8 DRUGS AS MEDICATIONS IN DUAL DISORDERS Track: Useful Chair: Psychotropic Drugs Enrique Baca, Universidad Autónoma de Barcelona, España. Speaker: Rafael Maldonado, Universidad Pompeu Fabra. Barcelona, España.
16:45 – 17:30 Main Lecture - ML02 Room 8 ARE EXISTING PSYCHIATRIC DIAGNOSES ABLE TO DESCRIBE DUAL DISORDERS IN Track: Psychosis THE LIGHT OF A WIDENING COMORBIDITY? Chair: Cristina Molina, Direcció General de Planificació i Recerca en Salut, Departament de Salut. Generalitat de Catalunya. Barcelona, España. Speaker: Pier Maria Furlan, Dept. of Mental Health and Drug Abuse, Turin, Italy.
www.cipd2015.com Pág. 3
th Friday April 17 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
16:00 – 17:30 Symposium - SY08 Room 9 ENHANCING CARE FOR ADOLESCENTS WITH DUAL DISORDERS: OUTREACH PREVENTION Track: Child & EFFORTS, PEDIATRIC HEALTH EVALUATIONS AND SUICIDAL RISK ASSESSMENT Adolescent Psychiatry Chair: Gabriel Kaplan, Bergen Regional Medical Center, Paramus. NJ, USA. Speakers: CANNABIS HEALTH RISKS AND PREVENTION PROGRAMS Mònica Prat, Hospital Universitari Vall d'Hebron. Barcelona, España. PEDIATRIC HEALTH EVALUATION Donald E. Greydanus, Western Michigan Univ. SchooloOf Medicine, Kalamazoo. MI, USA. SUICIDAL RISK ASSESSMENT Gabriel Kaplan, Bergen Regional Medical Center, Paramus. NJ, USA.
16:00 – 16:45 Workshop - WS01 Room 10 ASSERTIVE OUTREACH SERVICES IN DUAL DISORDERS. STATE OF THE ART, AND THE Track: Multidisciplinary NORWEGIAN SOLUTION IN COMMITTED, COMMUNITY COLLABORATION - THE C-FLEX Intervention in Dual MODEL Disorders Chair: Bror Just Andersen, Baerum DPC, Veste Viken HT, Norway. Speakers: INTERDISCIPLINARY ASSERTIVE OUTREACH TEAMS IN DUAL DISORDERS - STATE OF THE ART Lars Linderoth, Vestre Viken HT/Baerum DPC, Norway. THE DEVELOPMENT, EXPERIENCE AND SUCCESS FACTORS WITH THE C-FLEX TEAM Kjetil Emilsen, Vestre Viken HT/Baerum DPC, Norway. THE WAY AHEAD - ESTABLISHING A C-FLEX YOUTH TEAM Aslak Woien Augedal, Vestre Viken HT/ Division of Mental Health And Addiction, Norway. METHODICAL APPROACH AND RESULTS OF THE EFFECT EVALUATION OF THE C-FLEX TEAM - THREE YEARS OF MODEL TESTING Bror Just Andersen, Baerum DPC, Veste Viken HT. Norway.
16:45 – 17:30 Workshop - WS02 Room 10 THE USE OF EAR ACUPUNCTURE TO AID IN RETENTION OF THOSE WITH BORDERLINE Track: Personality PERSONALITY DISORDER IN SUBSTANCE ABUSE TREATMENT Disorders Chair/Speaker: Elizabeth B. Stuyt, Colorado Mental Health Institute at Pueblo, Pueblo. CO, USA.
16:00 – 16:45 Symposium – SY09 Room 11 PROTOCOLS OF INTERVENTION IN DUAL PATHOLOGY Track: Training in Dual Chair: Diagnosis Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España. Speakers:
www.cipd2015.com Pág. 4
th Friday April 17 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Carlos Roncero, Universidad Autónoma de Barcelona, España. José Martínez-Raga, Unidad de Conductas Adictivas de Gandía, CEU Cardenal Herrera. Valencia, España.
16:45 – 17:30 Special Lecture – SL01 Room 11 DUAL PATHOLOGY AND ART Co-organized by the Foundation on Dual Disorders Chair: Lara Grau-López, Hospital Universitari Vall d’Hebron. Barcelona, España. Speaker: J. Ramon Pigem, Clínica Bellavista, Lleida, España.
16:00 – 17:30 Oral Communications - OC01 Room 12 Chairs: José Antonio Navarro, Hospital Universitario Vall d’Hebron de Barcelona/Clínica Galatea. Barcelona, España. Cecilia Idiarte, Sociedad de Psiquiatría del Uruguay, Uruguay.
EXECUTIVE FUNCTIONING, SUICIDE ATTEMPTS AND SUBSTANCE RELAPSES IN PATIENTS WITH AND WITHOUT PSYCHIATRIC COMORBIDITY I. Benaiges1, S. López-Vera1 J. E. Marquez-Arrico1, G. Prat1, A. Adan1, 2 1 Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, España. 2 Institute for Brain, Cognition and Behavior (IR3C), Barcelona, España.
CANNABIS: SU INFLUENCIA A LO LARGO DE UN AÑO EN LOS INTENTOS DE SUICIDIO M. Canal Rivero1,2, A. Yañez Castro1, G. Benítez Rodriguez1, J. García Egea1, Jordi E. Obiols2, M. Ruiz Veguilla1,3 1 Hospital Universitario Virgen del Rocío. Sevilla, España. 2 Facultat de Psicología. Departament de Psicología Clínica i de la Salut. Universitat Autònoma de Barcelona, España. 3 Instituto de Biomedicina de Sevilla (IBIS), España.
PERSONALITY DISORDERS, SUBSTANCE USE DISORDER AND CRIMINAL BEHAVIOR Anna C. S. Chaves University of São Paulo, São Paulo, Brasil.
PERIPHERAL TEMPERATURE CIRCADIAN RHYTHM IN PATIENTS WITH DUAL DIAGNOSIS: MENTAL DISORDER AS A MODULATING FACTOR S. López-Vera 1, I. Benaiges1, J.A. Madrid2, A. Adan1,3 1 Department of Psychiatry and Clinical Psychobiology, University of Barcelona, España. 2 Chronobiology Laboratory, Department of Physiology, University of Murcia, España. 3 Institute for Brain, Cognition and Behavior (IR3C), Barcelona, España.
www.cipd2015.com Pág. 5
th Friday April 17 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
THE CO-MORBIDITY BETWEEN SUICIDE VICTIMS IN THE DISTRICT OF TIRANA, OVER THE TIME PERIOD 2001-2010 Pasho Maksuti1, Vuksan Kola1, Artan Simaku3 1 UHC (University Hospital Centre) “Mother Theresa”, Tirana, Albania. 2 Institute of Public Health, Tirana, Albania.
FOCUS GROUPS: A METHOD FOR DEVELOPING GUIDELINES FOR DUAL DIAGNOSIS F. Matthys 1, P. Joosten2, W. van den Brink3, B. Sabbe4 1 University Hospital Brussels and Vrije Universiteit Brussels (VUB), The Netherlands. 2 Psychiatric Centre Broeders Alexianen, Tienen, Belgium. 3 Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center,University of Amsterdam, Amsterdam, The Netherlands. 4 Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium.
ADDICTION AND MENTAL PRODUCTIONS IN TRAUMATIC PATHOLOGIES Freddy nyegue1, Mlle Laurine Fort2 1 Centre Psychothérapique de Laxou/ Nancy, France. 2 Université de Lorraine, France.
THE EFFECT OF ACADEMIC SELF-EFFICACY AND SELF-AWARENESS ON ACADEMIC ACHIEVEMENT IN STUDENTS WITH LEARNING DISABILITY (LD) Moluk Khademi Ashkezari, Salehe Piryaei Alzahra University, Tehran, Iran.
MEN'S MENTAL HEALTH AND DUAL DISORDERS L. Sher Icahn School of Medicine at Mount Sinai and James J. Peters Veterans’ Administration Medical Center, New York, USA.
17:30 - 18:30 h.
17:30 – 18:30 Plenary Session - PS01 Auditorium A TREATMENT AND 42-MONTH FOLLOW-UP OF PRESCRIPTION OPIOID DEPENDENCE: THE Track: Opioid System ROLE OF DUAL DISORDERS and Dual Disorders Chair: Miguel Casas, Universitat Autònoma de Barcelona, Hospital Universitari Vall d’Hebron. Barcelona, España. Speaker: Roger Weiss, Harvard Medical School/division of Alcohol and Drug Abuse, McLean Hospital, Belmont. MA, USA.
www.cipd2015.com Pág. 6
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
08:30 – 10:00 h.
08:30 – 10:00 Symposium – SY10 Auditorium A MANAGEMENT OF SUBSTANCE USE DISORDERS IN PATIENTS WITH ADHD Track: Attention Deficit Chair: Josep A. Ramos-Quiroga, Hospital Universitari Vall d'Hebron. Barcelona, España. Speakers: TREATMENT OF COCAINE DEPENDENCE IN ADULTS WITH ADHD Frances Levin, New York Presbiterian Hospital, NYS Psychiatric Institute. NY, USA. ADHD MEDICATION USE AND MISUSE IN ADOLESCENCE Geurt van de Glind, Amsterdam Institute for Addiction Research. Amsterdam, The Netherlands. TRAUMA IN SUD PATIENTS WITH AND WITHOUT ADHD Maija Konstenius, Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet. Solna, Sweden. IS THE METHYLXANTHINE'S CONSUMPTION INCREASED IN ADULTS WITH ADHD? Josep A. Ramos-Quiroga, Hospital Universitari Vall d'Hebron. Barcelona, España.
08:30 – 10:00 Debate Forum - DF02 Auditorium B TRASCENDENCE OF SPIRITUALITY AND DUAL DISORDERS Track: Spirituality and Chair: Dual Disorders Adolf Tobeña, Catedrático de Psiquiatría y Psicología Médica. Universitat Autònoma de Barcelona, España. Speakers: SELF-HELP AND SPIRITUALITY Adil Qureshi, Universitat Autònoma de Barcelona, Hospital Vall d'Hebron. Barcelona, España. INTERVIEW ON SPIRITUALITY IN DUAL PATIENTS Jaime Roig, Centre Medic Alella. Barcelona, España.
08:30 – 09:15 Main Lecture - ML03 Room 1 DUAL DISORDERS IN THE JOURNAL ADDICTION Track: Training in Dual Chair: Diagnosis Miquel Roca, Universidad de las Islas Baleares. Mallorca, España. Speaker: Robert West, Health Behavior Research, Department of Epidemiology, University College London, United Kingdom.
09:15 – 10:00 Main Lecture - ML04 Room 1 DELAYED GRATIFICATIONS AND DUAL PATHOLOGIES: THE PRICE OF MODERNITY Track: Basic Research Chair: Joan Colom, Agència de Salut Pública de Catalunya, España. Speaker: Ruben Baler, National Institute on Drug Abuse, Bethesda. MD, USA.
www.cipd2015.com Pág. 7
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
08:30 – 10:00 Invited Symposium - IS01 Room 2-3 THE ONGOING DEBATE: CANNABIS AND DUAL DISORDERS Track: Cannabis and Chair: Dual Disorders Amine Benyamina, Centre d'Enseignement, de Recherche et de Traitement des Addictions. Paris, France. Speakers: CANNABIS ABUSE AND SHORT PSYCHOTIC EPISODES Mehdi Paes, Mohamed V Universityin Rabat, Morocco. CANNABIS USE IN CHRONIC SCHIZOPHRENIA PATIENTS Carmen Barral, Hospital Universitari Vall d'Hebron. Barcelona, España.
08:30 – 10:00 Symposium - SY11 Room 4 RELEVANCE OF SUBSTANCE USE DISORDERS (SUD) IN A LONG LIFESPAN: PROGRAM OF TPL Track: Personality BARCELONA GROUP Disorders Chair: Marc Ferrer, Hospital Universitari Vall d'Hebron. Barcelona, España. Speakers: THE IMPORTANCE OF SUBSTANCE USE DISORDER IN A PROGRAM FOR THE BORDERLINE PERSONALITY DISORDER (BPD) THROUGHOUT LIFE Mercè Gibert, Universitat Autònoma de Barcelona, Hospital Vall d'Hebron. Barcelona, España. THE IMPORTANCE TO TREAT THE SUBSTANCES USE DISORDER COMORBIDITY Joan Vegué, Universitat Autònoma de Barcelona, Servei de Psiquiatria en Hospital Vall d'Hebron. Barcelona, España SUBSTANCE USE DISORDERS (SUD) IN BORDERLINE PERSONALITY DISORDER (BPD): INFLUENCE AT CLINICAL MANIFESTATION Natalia Calvo, Universitat Autònoma de Barcelona, Hospital Vall d'Hebron. Barcelona, España.
08:30 – 10:00 Invited Symposium - IS02 Room 5 DUAL DISORDERS IN THE MODERN WORLD: TRANSCULTURAL APPROACH Track: Transcultural Chair: Psychiatry Dinesh Bhugra, King’s College London, United Kingdom. Speakers: CULTURAL INTERVIEW IN DUAL PATIENTS Francisco Collazos, Hospital Universitari Vall d'Hebron, Barcelona, España. IMMIGRATION, SOCIAL PSYCHIATRY AND DUAL PATHOLOGY Dinesh Bhugra, King’s College London, United Kingdom. IS DUAL DISORDER DIFFERENT IN LATIN POPULATIONS AMONG LATINOS IN USA? Margarita Alegria, Center for Multicultural Mental Health Research, Cambridge Health Alliance & Harvard Medical School, Somerville. MA, USA.
08:30 – 10:00 Symposium - SY12 Room 6 RESPONSE PREDICTION IN HEROIN-ASSISTED TREATMENT: THE ROLE OF DUAL DISORDERS
www.cipd2015.com Pág. 8
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Track: Opioid System Chair: and Dual Disorders Wim van den Brink, University of Amsterdam/Amsterdam Institute for Addiction, The Netherlands. Speakers: COMORBID COCAINE DEPENDENCE IN HEROINE-ASSISTED TREATMENT: PREDICTING OUTCOME A TREATING POLYDRUG ADDICTION Wim van den Brink, University of Amsterdam/Amsterdam Institute for Addiction, The Netherlands. OUTCOMES FOR PSYCHIATRIC COMORBIDITY IN HEROIN ASSISTED TREATMENT: PREDICTIVE FACTORS Ambros Uchtenhagen, Swiss Research Institute for Public Health and Addiction, Zurich, Switzerland. Teodora Groshkova, Centre for Health Evaluation & Outcome Sciences, Providence Health Care, Canada. RESPONSE TO INJECTABLE OPIOID TREATMENT IN PARTICIPANTS WITH MODERATE VS. LOW PSYCHOPATHOLOGY SYMPTOMS Eugenia Oviedo-Joekes, National Addiction Centre, King's College London. London, United Kingdom.
08:30 – 10:00 Debate Forum - DF03 Room 7 DRUGS FOR USE IN CONDITIONS DIFFERENT TO THOSE AUTHORIZED IN DUAL DISORDERS: Track: CONSENSUS OF THE SEPD Psychopharmacological Chair: Treatments in Dual Francisco J. Álvarez, Institute for The Study of Alcohol and Drugs, Universidad de Valladolid, Disorders España. Speakers: CONSENSUS OF SEPD ON DUAL BIPOLAR DISORDER TREATMENT Vicent Balanzá, La Fe University and Polytechnic Hospital, University of Valencia, CIBERSAM. Valencia, España. CONSENSUS OF SEPD ON DUAL DISORDER ANXIETY TREATMENT Marisa Dorado, Unidad de Conductas Adictivas De Gandía. Valencia, España. CONSENSUS OF SEPD ON DUAL DISORDER DEPRESSION TREATMENT: PRELIMINARY PROPOSAL OF THE WORKING GROUP Pablo Vega, Instituto de Adicciones. Madrid, España.
08:30 – 10:00 Debate Forum - DF04 Room 8 HOW TO STOP THE TRAIN BEFORE IT CRUSHES OR DERAILS? ASSESSMENT AND Track: PREVENTION OF DUAL PATHOLOGY IN ADOLESCENCE Psychotherapeutic Chair: Treatment in Dual Rosa Fernández-Marcote, UCA de Toledo, Hospital Provincial, SESCAM. Toledo, España. Disorders EFFECTIVE PSYCHOLOGICAL INTERVENTIONS IN ADOLESCENTS WITH DUAL PATHOLOGY. FROM PREVENTION TO TREATMENT Lorena Casete, Unidad Asistencial de Drogodependencias. ACLAD. A Coruña, España. DUAL TEENS Raquel Vidal, Hospital Universitari Vall de Hebrón. Barcelona, España. WHAT ABOUT "OUR" TEENS? CODEPENDENCIES AND RISKS
www.cipd2015.com Pág. 9
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Angel M. Turbi, Universidad Católica de Valencia. S Vicente Mártir. Valencia, España. PSYCHOMETRIC EVALUATION TOOLS IN DUAL PATHOLOGY Constanza Daigre, Servicio de Psiquiatría Hospital Universitario Vall d’Hebron, Barcelona, España.
08:30 – 10:00 Medical Educational Room Room 9 Sponsored by the Foundation on Dual Disorders
08:30 – 10:00 Symposium - SY13 Room 10 NOVEL APPROACHES TO UNDERSTANDING AND TREATING COMORBID DEPRESSION AND Track: Alcohol ALCOHOL MISUSE Chair: Marie-Eve Couture, Dalhousie University. Halifax, Canada. Speakers: A QUALITATIVE STUDY OF DRINKING TO COPE WITH DEPRESSION Marie-Eve Couture, Dalhousie University. Halifax, Canada. CONTEXT COUNTS: SOLITARY DRINKING EXPLAINS THE ASSOCIATION BETWEEN DEPRESSIVE SYMPTOMS AND ALCOHOL-RELATED PROBLEMS Matthew Keough, Concordia University. Montréal, Canada. THE EFFECTS OF DEPRESSION LEVEL AND ALCOHOL ADMINISTRATION ON POSITIVE AND NEGATIVE POST-EVENT RUMINATION: AN EXPERIMENTAL STUDY Sherry H. Stewart, Dalhousie University. Halifax, Canada. INTERVENING WITH HOPELESSNESS REDUCES AND PREVENTS DEPRESSION AND ALCOHOL MISUSE IN ADOLESCENTS Patricia Conrod, Université de Montréal, Canada.
08:30 – 09:15 Main Lecture - ML05 Room 11 CORMORBIDITY OF SUBSTANCE AND PSYCHIATRIC DISORDERS: EPIDEMIOLOGIC FINDINGS, Track: Epidemiology and NEW DIRECTIONS Dual Disorders Chair: Pere Bonet, Pere Bonet Gabinet Psiquiatria i Psicologia Clínica, Manresa. Barcelona, España. Speaker: Deborah Hasin, New York State Psychiatric Institute, Columbia University. NY, USA.
09:15 - 10:00 Workshop - WS03 Room 11 ADOPTED AND NON-ADOPTED TEENAGERS AND YOUNG ADULTS WITH DUAL DISORDERS: Track: Child & DIFFERENTIAL DIAGNOSTIC CHARACTERISTICS Adolescent Psychiatry Chair: Jordi Royo, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y sus Familias. Barcelona, España. Speakers: ADOPTED AND NON-ADOPTED ADOLESCENTS: CRITERIA FOR RESIDENTIAL ADMISSION TO SPECIALISED HEALTHCARE FACILITIES Ramon Martí, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y sus Familias. Barcelona, España.
www.cipd2015.com Pág. 10
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
COMPARATIVE DIAGNOSTIC STUDY IN ADOPTED AND NON-ADOPTED ADOLESCENTS AND YOUNG ADULTS AT SPECIALISED HEALTHCARE CENTRES Cristina Baliarda, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y sus Familias. Barcelona, España.
08:30 – 10:00 Oral Communications - OC02 Room 12 Chairs: Nicolás Ramírez, Hospital Sant Rafael, Barcelona, España. Ligia Chavez, Universidad de Puerto Rico. San Juan, Puerto Rico.
TIME TREND ANALYSIS OF PATIENTS WITH DUAL SEEKING TREATMENT FROM DUAL DIAGNOSIS CLINIC OF A TERTIARY CARE SUBSTANCE USE DISORDER TREATMENT CENTRE IN INDIA Y.P.S.Balhara, R. Gupta, R. Lal India Institute of Medical Sciences (AIIMS), New Delhi, India.
PERPETRATOR OF FACTITIOUS DISORDER ON ANOTHER RECEIVES AN INTERNAL SELF- REWARD IN THE MEDICAL ENVIRONMENT. ADDICTIVE BEHAVIOR? M. López-Rico1, J. López-Sánchez López J.1, J.L. Jiménez Hernández2 1 Facultad de Medicina. Universidad de Salamanca, España. 2 Hospital "Doce de Octubre". Madrid, España.
PSYCHIATRIC DISORDERS AND HIV-HCV COINFECTION: NEED FOR BETTER SCREENING AND CONTINUOUS CARE L. Michel1, M. Winnock2, C. Protopopescu3, M.A. Loko2, J.P. Lang4, B. Spire3, D. Salmon5, F. Dabis3, M.P. Carrieri3 1 Centre Pierre Nicole; Inserm, U669, Paris, France. 2 Inserm, U897, ISPED, Bordeaux, France. 3 Inserm, (SESSTIM), Marseille, France. 4 CHRU Strasbourg, Strasbourg, France. 5 Hôpital Cochin Port-Royal, Paris, France.
A BROAD UNDERSTANDING OF GAMING ADDICTION: GAMERS’ THOUGHTS, PERCEPTIONS AND BEHAVIOURS IN GAME TRANSFER PHENOMENA A. Ortiz de Gortari, M.D Griffiths Nottingham Trent University, Nottingham, United Kingdom.
DRUG AND SYMPTOMS OF PATHOLOGICAL GAMBLING IN COLOMBIAN PRISON POPULATION J. Ruíz Pérez, O. Garay Quevedo, L. Rueda Useche Facultad de Ciencias Humanas, Universidad Nacional de Colombia, Bogotá, Colombia.
DETERMINE THE EFFECT OF TREATMENT ON RETENTION AMONG DRUG USERS Peymaneh Shirinbayan, Hassan Rafiey, Afshin Vejdani Roshan, Asghar dadkhah, Ali
www.cipd2015.com Pág. 11
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Farhoudian University of Social welfare and rehabilitation sciences, Tehran, Iran.
AUTISM SPECTRUM DISORDERS IN DUAL-DIAGNOSIS PATIENTS – PREVALENCE STUDY CONDUCTED AT A DUAL DIAGNOSIS TREATMENT FACILITY A.E. Bonebakker1, S. van Nieuwerk1, R. Vuijk2, P. Blanken3 1 Palier Centre for Dual Disorders, The Hague, The Netherlands. 2 Sarr Expertise Centre of expertise in autism, Rotterdam, The Netherlands. 3 Parnassia Addiction Research Centre, The Hague, The Netherlands.
DSM-IV DIAGNOSES AMONG A COMMUNITY SAMPLE OF CHINESE ADOLESCENTS: RATES AND PATTERNS OF COMORBIDITY Patrick Leung The Chinese University Of Hong Kong, China.
SYSTEMS OF CARE FOR DUAL DISORDERS: THE CANADIAN EXPERIENCE N. El-Guebaly University of Calgary, Alberta, Canada.
10:00 – 12:00 h.
10:00 – 12:00 SATELLITE Symposium Room 1 Industry Session not included in official scientific programme CME/CPD
10:00 – 12:00 SATELLITE Symposium Room 2-3 Industry Session not included in official scientific programme CME/CPD
10:00 – 12:00 SATELLITE Symposium Room 6 Industry Session not included in official scientific programme CME/CPD
12:00 – 14:00 h.
12:00 – 14:00 SATELLITE Symposium Room 1 Industry Session not included in official scientific programme CME/CPD
12:00 – 14:00 SATELLITE Symposium Room 2-3 Industry Session not included in official scientific programme CME/CPD
12:00 – 14:00 Supported WORKSHOP Room 11 Industry Session not included in official scientific programme CME/CPD
www.cipd2015.com Pág. 12
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
14:00 – 15:30 h.
14:00 – 15:30 Invited Symposium - IS03 Auditorium A SMOKE IN YOUR EYES Track: Tobacco Chair: Robert West, Health Behavior Research, Department of Epidemiology, University College London, United Kingdom. Speakers: DEPRESSION AND ADDICTION, DOES TOBACCO AFFECT Eugeni Bruguera, Hospital Universitari Vall d'Hebron. Barcelona, España. TREATMENT OF TOBACCO DEPENDENCE AND ITS INFLUENCE ON OTHER ADDICTIONS Robert West, Health Behavior Research, Department of Epidemiology, University College London, United Kingdom. CHOLINERGIC SYSTEM AND TOBACCO AND DUAL DISORDERS Manuel Gurpegui, Universidad de Granada, España.
14:00 – 15:30 Debate Forum - DF05 Auditorium B PERSONALITY FEATURES OR PERSONALITY DISORDERS: DOES IT MATTER IN DUAL Track: Personality DISORDERS? Disorders Chair: Jose L. Carrasco, Universidad Complutense de Madrid, España. Speakers: THERAPEUTIC STRATEGIES OF SUBSTANCE USE DISORDER WITH COMORBIDITY OF BORDERLINE PERSONALITY DISORDER Miquel Gasol, Psiquiatría y Psicología del Hospital General de Catalunya. Barcelona, España. TRAITS, TROUBLES AND SUBSTANCE USE Lola Peris, Centre de Neuchâtelois de Psychiatrie (CNP) Neuchàtel, Switzerland. THE IMPORTANCE OF (SUBSTANCE USE DISORDER) SUD IN THE COMPLEX PATHOGENESIS OF (BORDERLINE PERSONALITY DISORDER) BPD Marc Ferrer, Hospital Universitari Vall d'Hebron. Barcelona, España.
14:00 – 15:30 Invited Symposium - IS04 Room 1 ARE GENETICS RISK FACTORS FOR DUAL DISORDERS? Track: Basic Research Chair: Henry R. Kranzler, Perelman School of Medicine, University of Pennsylvania. Treatment Research Center. PA, USA. Speakers: CANNABIS USE AND SCHIZOPHRENIA FROM THE PERSPECTIVE OF THE GENETIC FACTORS Araceli Rosa, Universidad de Barcelona, España. GENETIC RISK FACTORS FOR DRUG ADDICTION Noelia Fernández, Genetics Department, UB. CIBERER. Barcelona, Spain. POLYMORPHISMS AND THE EFFICACY OF METHADONE Francina Fonseca, Hospital del Mar. Barcelona, España.
www.cipd2015.com Pág. 13
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
14:00 – 15:30 Invited Symposium - IS05 Room 2-3 CANNABIS, PSYCHOSIS AND DUAL DISORDERS Track: Cannabis and Chair: Dual Disorders Alan Green, Department of Psychiatry, Dartmouth Medical School, Lebanon. MD, USA. Speakers: FIRST PSYCHOTIC EPISODES; CANNABIS AND DUAL PATHOLOGY Luis San, Hospital Sant Joan de Deu. Barcelona, España. EVALUATION OF CANNABIS CONSUMPTION IN PSYCHOTIC DUAL PATIENTS Alan Green, Department of Psychiatry, Dartmouth Medical School, Lebanon. MD, USA. USE OF CANNABIS AND ITS INFLUENCE IN ON DEVELOPMENT Miguel Ruiz-Veguilla, Hospital Virgen del Rocío. Sevilla, España.
14:00 – 15:30 Symposium – SY14 Room 4 THE CONVERGENCE OF ADDICTION MEDICINE AND DUAL DISORDERS Track: Training in Session in collaboration with ISAM, ACAPI and SEPD Dual Diagnosis Chair: Gregory Bunt, International Society of Addiction Medicine, NYU School of Medicine. NY, USA. Speakers: Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España. Nady El-Guebaly, University of Calgary. Alberta, Canada. Javier Didia, Hospital Italiano de Buenos Aires y Universidad de Buenos Aires, Argentina.
14:00 – 15:30 Symposium - SY15 Room 5 NEUROPSYCHOLOGICAL PERFORMANCE ON DUAL DISORDERS Track: Evaluation Chair: processes in Dual Ana Adan, Instituto de Investigación en Cerebro, Cognición y Conducta de la Universidad de Disorders Barcelona, España. Speakers: NEUROPSYCHOLOGICAL IMPACT OF DUAL DISORDERS. CURRENT KNOWLEDGE Gemma Prat, Universitat de Barcelona, España. NEUROPSYCHOLOGICAL ASSESSMENT IN DUAL DISORDER PATIENTS. SELECTING TASKS TO OPTIMIZE THE EVALUATION Carlos Jacas, Hospital Universitari Vall d'Hebron. Barcelona, España. NEUROCOGNITIVE PERFORMANCE OF DUAL SCHIZOPHRENIA: A POSSIBLE BIOMARKER Irina Benaiges, Universitat de Barcelona, España.
14:00 – 15:30 Symposium – SY16 Room 6 FETAL ALCOHOL SPECTRUM DISORDER AS A GENERATOR OF DUAL PATHOLOGY Track: Psychosis Chair: Montse Pàmias, Corporació Sanitaria I Unviersitari Parc Taulí, Sabadell. Barcelona, España. Speakers: EAF: EPIDEMIOLOGY AND A SKI CLINIC
www.cipd2015.com Pág. 14
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Anna Sans, Hospital Sant Joan de Déu D' Esplugues. Barcelona, España. NEUROPSYCHOLOGY AND LEARNING IN THE EAF Natália Picó, Fundació Institut de Psicologia. Barcelona, España. PSYCHIATRIC COMORBIDITY IN THE EAF Núria Gómez, Hospital Universitari Vall d´Hebron. Barcelona, España.
14:00 – 15:30 Symposium - SY17 Room 7 ALCOHOL AND AGRESSION: AN INTIMATE RELATIONSHIP! Track: Alcohol Chair: Sandra Queirós, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal. Speakers: ALCOHOL AND SEXUAL ASSAULT Sandra Queirós, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal. ALCOHOL AND AGRESSION - VICTIMS AND THE SNOWBALL EFFECT Tânia Abreu, Centro Hospitalar Tamega E Sousa. Penafiel, Portugal. ALCOHOL, SEVERE MENTAL ILLNESS AND AGRESSION Catarina Freitas, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal. ALCOHOL, ANTISOCIAL PERSONALITY AND AGRESSION Teresa Sousa-Ferreira, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal.
14:00 – 15:30 Debate Forum - DF06 Room 8 EFFECTIVENESS OF PSYCHOLOGICAL TREATMENTS IN DUAL PATHOLOGY AND ADEQUACY Track: OF RESOURCES. HAVE WE CHANGED ONE ADDICTION FOR ANOTHER? Psychotherapeutic Chair: Treatment in Dual Rita Martín, C. de Día "Cercado Del Marqués" ACJ San Miguel. Tenerife, España. Disorders Speakers: PSYCHOLOGICAL INTERVENTION IN DUAL PATHOLOGY: AN INTEGRATED NETWORK MODEL OF SOCIAL AND HEALTH RESOURCES IN THE CITY OF BARCELONA Cristo M. Cruz, Centre d'Atenció i Seguiment Sarrià. Barcelona, España. TREATMENT, EFFICACY AND THE FIGURE OF THE PSYCHOTHERAPIST Mª Elena Bernal, Servicio Provincial de Drogodependencias de la Diputación de Almería, España. PSYCHOTHERAPIES IN DUAL PATHOLOGY Diana Kushner, Universidad de Santiago de Chile. Santiago, Chile. EVOLUTION OF TREATMENT PROGRAMS IN DUAL PATHOLOGY Abel Baquero, PPDG Consorcio Hospitalario Provincial de Castellón. Comunidad Valenciana, España.
14:00 – 15:30 Medical Educational Room Room 9 Sponsored by the Foundation on Dual Disorders
14:00 – 15:30 Symposium - SY18 Room 10 IDENTIFYING STRATEGIES FOR IMPROVING CARE FOR LATINO IMMIGRANTS WITH DUAL Track: Transcultural DISORDERS IN SPAIN AND THE U.S.: RESULTS FROM THE INTERNATIONAL LATINO
www.cipd2015.com Pág. 15
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Psychiatry RESEARCH PARTNERSHIP Chair: Margarita Alegria, Harvard Medical School, Somerville. MA, USA. Speakers: COMPARISON OF MENTAL HEALTH TREATMENT EXPENDITURES AMONG PATIENTS WITH DUAL DISORDERS IN USUAL PSYCHIATRIC CARE BETWEEN MADRID AND BOSTON HOSPITAL SYSTEMS Rodrigo Carmona, Fundación Jiménez Diaz. Madrid, España. AN INTERNATIONAL COMPARISON OF EPISODES OF SUBSTANCE ABUSE TREATMENT AMONG NATIVE-BORN AND LATINO IMMIGRANTS IN PUBLIC HOSPITAL SETTINGS IN BARCELONA AND BOSTON Adil Qureshi, Universitat Autònoma de Barcelona, Hospital Vall d'Hebron. Barcelona, España. COMMONALITIES AND DIFFERENCES IN BEHAVIORAL HEALTH CARE FOR LATINO POPULATIONS IN PRIMARY CARE Daniel Gonzalez, Cambridge Health Alliance, Somerville. MA, USA. THE TESTING OF THE AC-OK WITH AN INTERNATIONAL SAMPLE OF LATINO IMMIGRANTS Ligia Chavez, Universidad de Puerto Rico. San Juan, Puerto Rico.
14:00 – 14:45 Workshop - WS04 Room 11 ADDICTIONS AND DUAL DISORDERS IN JUVENILE JUSTICE Track: Child & Chair: Adolescent Psychiatry Rosa de Sta. Mª Pérez, Parc Sanitari Sant Joan de Deu. Barcelona, España. Speakers: MENTAL HEALTH CARE AND SUBSTANCE ABUSE IN YOUNG OFFENDERS: AN INTEGRATIVE APPROACH TO HEALTH CARE IN THE FIELD OF JUVENILE JUSTICE IN SPAIN Jorge M. Garcia, Hospital Punta de Europa de Algeciras. Cádiz, España. VULNERABILITY AND DUAL PATHOLOGY IN YOUNG OFFENDERS Jaume Martinez, Unitat Terapéutica de Justica Juvenil Els Til·lers. Barcelona, España. SPECIFICS OF THE MANAGEMENT AND TREATMENT OF DUAL PATHOLOGY IN TEENAGERS WITH MANY PROBLEMATIC QUESTIONS Jaume Claramunt, Parc Sanitari Sant Joan de Deu. Barcelona, España.
14:45 – 15:30 Workshop - WS05 Room 11 ADDICTION TO INFORMATION TECHNOLOGY AND COMMUNICATION AND BORDERLINE Track: Personality PERSONALITY DISORDER Disorders Chair: Maite Utges, Hospital Santa Maria. Lleida, España. Speakers: THE ADDICTION TO INFORMATION TECHNOLOGY AND COMMUNICATION AND BORDERLINE PERSONALITY DISORDER, A DANGEROUS COMBINATION Maite Utges, Hospital Santa Maria. Lleida, España. APPROPRIATE USE OF INFORMATION AND COMMUNICATION TECHNOLOGIES (ICTS) IN THE TREATMENT OF BORDERLINE PERSONALITY DISORDER (BPD) Enrique Díaz, Club Aragon Activo S.L. Zaragoza, España.
www.cipd2015.com Pág. 16
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
14:00 – 15:30 Oral Communications - OC03 Room 12 Chairs: José M. Goikolea, Hospital Clinic, Barcelona, España. Pier P. Pani, Social-Health Services, Health District 8, Cagliari, Italy.
FORENSIC PSYCHIATRIC SERVICES IN THE ARAB WORLD, THE PAST AND THE FUTURE Hasanen Al-Taiar1, Saif Al-Hashimi2, Moustafa Hussien Soltan3 1 Oxford Health NHS Foundation Trust, United Kingdom. 2 Armed Forces Hospital. Muscat, Oman. 3 Egypt.
ABUSE OF VIDEO GAMES AND THE INTERNET IN A CASE OF AUTISM R. Cappai, S. Marras, I. Obbili Studio di Psicologia, Costruttivamente. Cagliari, Italy.
AN EXPLORATORY ONLINE SURVEY ON THE PREVALENCE OF HYPERSEXUAL BEHAVIOUR R. Gupta, D. Deka, YPS. Balhara All India Institute of Medical Sciences, New Delhi, India.
LIMES, LIMEN. BORDERLINE PERSONALITY DISORDER AND SUBSTANCES ABUSE: TWO LINKED PATHOLOGIES ON THE BORDER BETWEEN NEUROLOGY AND PSYCHIATRY, LAW AND CLINIC Marco Mollica, Veronica Aiello DINOGMI, Section of Psychiatry, University of Genoa, San Martino Hospital, Largo Rosanna Benzi 1, Genoa, Liguria, Italy.
FEATURES AND PERMANENCE IN TREATMENT OF A SAMPLE OF DRUG USERS LEGALLY CONDITIONED TO TAKE TREATMENT IN CENTERS OF YOUTH INTEGRATION TLALPAN C. Tejeda Romero1, DB Díaz Negrete2 1 Centros de Integración, Tlalpan, DF, México. 2 Centros de Integración Juvenil, DF, México.
BUILDING AN INDIVIDUALIZED PROFILE FOR TREATMENT ACROSS BEHAVIORAL ADDICTIONS N. el-Guebaly1.2 1 University of Calgary, Alberta, Canada. 2 Alberta Gambling Research Institute, Alberta, Canada.
AN INDIVIDUAL WITH COMORBID BIPOLAR AND POLYSUBSTANCE USE DISORDERS COMMITS HOMICIDE AFTER A TESTOSTERONE INJECTION: A CASE REPORT AND DISCUSSION L. Sher Icahn School of Medicine at Mount Sinai and James J. Peters Veterans’ Administration Medical Center, New York, USA.
www.cipd2015.com Pág. 17
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
NURSING INTERVENTION IN DRUG ADDICTION CENTERS (CAD) PROTOCOL S. Gutiérrez Cáceres1, J. Chicharro Romero2, M. Sáez García3, D. Coca Pérez4, J. Martín Herrero5, N. García Hidalgo6, N. Salgado Marcos6, C. López Jiménez5, A. Vicente Partido7, C. Culebras García5 1 DUE CAD Latina, Madrid, España. 2 DUE CAD San Blas, Madrid, España. 3 DUE CAD Hortaleza, Madrid, España. 4 DUE CAD Tetuan, Madrid, España. 5 DUE CAD Arganzuela, Madrid, España. 6 DUE CAD Vallecas, Madrid, España. 7 DUE CAD Villaverde, Madrid, España.
15:30 – 17:00 h.
15:30 – 17:00 Symposium – SY19 Room 1 ARE THERE CLINICAL-NEUROBIOLOGICAL DIFFERENCES BETWEEN CANNABIS USERS WITH Track: Psychosis PSYCHOSIS AND NON-USERS WITH PSYCHOSIS? Chair: Francisco Arias, Hospital Doce de Octubre. Madrid, España. Speakers: CLINICAL AND PREPULSE INHIBITION DEFICIT DIFFERENCES BETWEEN CANNABIS-INDUCED PSYCHOTIC DISORDER AND SCHIZOPHRENIA Gabriel Rubio, Universidad Complutense de Madrid. Madrid, España. DIFFERENCES IN TREATMENT AND EVOLUTION BETWEEN CANNABIS USERS AND NON- USERS AFTER STARTING THE FIRST PSYCHOTIC EPISODE PROGRAMME CARRIED OUT AT THE 12TH OCTOBER HOSPITAL, MADRID. Isabel Martínez, Hospital Doce de Octubre. Madrid, España.
15:30 – 17:00 Debate Forum - DF07 Room 2-3 CANNABIS: NEW INTERNATIONAL REGULATION. WHAT IS THE RISK IN DUAL DISORDERS? Track: Cannabis and Chair: Dual Disorders Manuel Mas-Bagá, CAT Barcelona, España. Speakers: NEW POLITICS ABOUT CANNABIS: AN OPORTUNITY IN PUBLIC HEALTH? Joan Colom, Agència de Salut Pública de Catalunya, BarcOC01elona, España. CANNABIS USE IN THE USA Ruben Baler, National Institute on Drug Abuse. MD, USA. LEGALIZATION OF THE USE OF CANNABIS Cecilia Idiarte, Sociedad de Psiquiatría del Uruguay, Uruguay.
15:30 – 17:00 Invited Symposium – IS06 Room 4 WHERE ARE DUAL DISORDERS IN DSM5? Track: Training Dual Chair:
www.cipd2015.com Pág. 18
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Diagnosis Marta Torrens, Institut de Neuropsiquiatria I Addiccions-Parc de Salut Mar, Universitat Autònom, Barcelona, España. Speakers: SUBSTANCE-RELATED AND ADDICTIVE DISORDERS IN DSM-5: WHAT'S NEW? Marc Auriacombe, Faculté de Médecine, Université de Bordeaux, France. DUAL DISORDERS IN DSM-5: AN OVERVIEW Deborah Hasin, New York State Psychiatric Institute, Columbia University. NY, USA. SOME EXAMPLES OF COMORBIDITY WITH SUD IN DSM-5 Frances Levin, New York Presbiterian Hospital, NYS Psychiatric Institute. NY, USA.
15:30 – 17:00 Symposium - SY20 Room 5 REHAB PROJECT AND OTHER DUAL DISORDERS APPROACHES IN EUROPEAN PRISONS Track: Penitentiary Chair: (Prisons) & Dual Fabio Sternberg, Federación Europea de Sanidad Penitenciaria. Barcelona, España. Pathology Speakers: DUAL DISORDERS APPROACH IN SPANISH PRISONS José M. Antolín, Sociedad Española de Sanidad Penitenciaria (SESP). Barcelona, España. DUAL DISORDERS APPROACH IN FRENCH PRISONS Fadi Meroueh, Asociación de Profesionales Sanitarios en Prisión (APSEP), Francia. Cyril Manzanares, Servicios Médicos de la Prisión Villeneuve Les Maguelone - CHU Montpellier, France. REHAB PROJECT AS AN APPROACH IN DUAL DISORDERS IN PRISON. THE VITERBO-ITALY EXPERIENCE Roberto Monarca, Sociedad Italiana de Medicina y Sanidad Penitenciaria (SIMSPe), Italy.
15:30 – 17:00 Symposium - SY21 Room 6 OUTCOME MEASURES IN HEROIN ADDICTED PATIENTS WITH DUAL DISORDERS TREATED Track: Evaluation WITH OPIOID AGONIST MEDICATIONS processes in Dual Chair: Disorders Icro Maremmani, University of Pisa, University of Siena, Santa Chiara University Hospital, Pisa, Italy. Speakers: INCREASING IMPORTANCE OF MEASURING OUTCOMES IN OPIOID DEPENDENCE CARE Icro Maremmani, University of Pisa, University of Siena, Santa Chiara University Hospital, Pisa, Italy. STUDYING PSYCHOPATHOLOGY OF HEROIN ADDICTS AS OUTCOME MEASURES Pier P. Pani, Social-Health Services, Health District 8 (ASL 8) Cagliari, Italy. QUALITY OF LIFE AND CRAVING BEHAVIOUR AS OUTCOME MEASURES IN HEROIN ADDICTS Angelo G.I. Maremmani, University of Pisa. Pisa, Italy.
15:30 – 17:00 Symposium - SY22 Room 7 ALCOHOL CONSUMPTION DURING ADOLESCENCE AS A VULNERABILITY FACTOR IN DUAL Track: Alcohol DISORDERS Chair: Olga Valverde, Universitat Pompeu Fabra. Barcelona, España. Speakers: DELETERIOUS EFFECTS OF ALCOHOL CONSUMPTION DURING CRITICAL PERIODS OF LIFE Olga Valverde, Universitat Pompeu Fabra. Barcelona, España. ETHANOL, STRESS AND ADOLESCENCE Marta Rodríguez-Árias, Universidad de Valencia. Comunidad Valenciana, España. NEUROCHEMICAL AND BEHAVIORAL CHANGES INDUCED BY MATERNAL SEPARATION AND
www.cipd2015.com Pág. 19
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
VULNERABILITY TO ALCOHOL CONSUMPTION IN MICE Jorge Manzanares, Universidad Miguel Hernández. Alicante, España. ADDICTION RESEARCH AND HUMAN PHARMACOLOGY GROUPS, NEUROSCIENCES RESEARCH PROGRAM, IMIM Francina Fonseca, Hospital del Mar. Barcelona, España.
15:30 – 17:00 Debate Forum - DF08 Room 8 MULTIDISCIPLINARITY IN DUAL PATHOLOGY AND ITS KEYS: PSYCHOLOGICAL Track: INTERVENTION Psychotherapeutic Chair: Treatment in Dual José A. Carrobles, Universidad Autónoma de Madrid, España. Disorders Speakers: TRANSDIAGNOSIS AND DUAL PATHOLOGY José A. Carrobles, Universidad Autónoma de Madrid, España. ROLE OF THE PSYCHOLOGIST: THE NEED TO INTEGRATE THE DISCIPLINE IN DUAL PATHOLOGY Mª Nieves Gómez, Ayuntamiento San Sebastian de Los Reyes, Madrid, España. THE ROLE OF THE PSYCHOLOGIST IN DUAL PATHOLOGY IN AN INTERDISCIPLINARY ADDICTIONS CARE TEAM Marcela Coromina, Centre d'Atenció i Seguiment Sarrià, Centre d'Atenció i Seguiment Baluard. Barcelona, España.
15:30 – 17:00 Medical Educational Room Room 9 Sponsored by the Foundation on Dual Disorders
15:30 – 17:00 Symposium – SY23 Room 10 ADDICTIVE DISORDERS IN ADHD PATIENTS: A SELF-MEDICATION PROBLEM? Track: Attention Deficit Chair: Jorge Jaber, Clínica Jorge Jaber. Rio de Janeiro, Brasil. Speakers: ADDICTIVE DISORDERS IN ADHA PATIENTS José Temótio, Unidade Patologia Dual. C.H.U. Coimbra, Portugal. NEUROBIOLOGY OF ADHA AND ADDICTIVE DISORDERS Eugenio H. Grevet, Federal University of Rio Grande do Sul (UFRGS). Porto Alegre Clinical Hospital. Porto Alegre, Brasil. SELF-MEDICATION HYPOTHESIS IN ADDICTIVE DISORDERS IN ADHA PATIENTS Célia Franco, Unidade Patologia Dual. C.H.U. Coimbra, Portugal.
15:30 – 16:15 Workshop - WS06 Room 11 BETWEEN EAST AND WEST: CHALLENGES IN TREATMENT OF PATIENTS WITH DUAL Track: Transcultural DISORDERS Psychiatry Chair: Andrej Kastelic, Center for Treatment of Drug Addiction, University Psychiatric Hospital Ljubljana, Slovenia. Speakers:
www.cipd2015.com Pág. 20
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
ARE THEY (WE) DIFFERENT? Nusa Segrec, Center for Treatment of Drug Addiction, University Psychiatric Clinic Ljubljana, Slovenia. BREAKING BARRIERS FOR TREATMENT OF DRUG USERS WITH DUAL DIAGNOSES WITH AIM TO IMPROVE THE ACCESS AND QUALITY OF TREATMENT Ljiljana Ignjatova, Psychiatric Hospital Skopje. Skopje, Macedonia. HOW STIGMA WILL DELAY A TREATMENT Luis Patricio, Casa de Saude De Carnaxide. Carnaixade, Portugal. TREATING PEOPLE WITH MENTAL HEALTH PROBLEMS AND ADDICTION IN CLOSED SETTINGS Andrej Kastelic, Center for Treatment Of Drug Addiction, University Psychiatric Hospital Ljubljana, Slovenia.
16:15 - 17:00 Workshop - WS07 Room 11 TREATMENT OF CHALLENGING BEHAVIOURS IN HIGH FUNCTIONING WOMEN WITH Track: Gender and AUTISM SPECTRUM DISORDER AND DUAL DISORDER Dual Diagnosis Chair: Patricia J.M. van Wijngaarden-Cremers, Dimence Mental Health. Deventer, The Netherlands. Speakers: Patricia J.M. van Wijngaarden-Cremers, Dimence Mental Health. Deventer, The Netherlands. Rutger Jan van der Gaag, Radboud University Medical Centre, Royal Dutch Medical Association. Utrecht, The Netherlands.
15:30 – 17:00 Oral Communications - OC04 Room 12 Chairs: Carmen Barral, Hospital Universitari Vall d'Hebron. Barcelona, España. Edgard Belfort, Hospital Psiquiátrico de Venezuela, Caracas, Venezuela.
FAMILY HISTORY OF SUBSTANCE ABUSE AND ITS IMPACT ON PSYCHOSOCIAL SKILLS PROGRAMS TO PREVENT SCHOOL VIOLENCE IN TEGUCIGALPA, HONDURAS Edwing Octavio Garcia Toro Facultad de Ciencias Médicas Universidad Nacional Autónoma de Honduras. Honduras.
TAKING THE PLUNGE- A QUALITATIVE STUDY OF HOPE WITHIN THE MENTAL HEALTH AND SUBSTANCE ABUSE SERVICES Knut Tore Sælør, Ottar Ness, Randi Semb Buskerud and Vestfold University College, Drammen, Norway.
COMPARATIVE STUDY OF UNIVERSITY STUDENTS, SONS OF ALCOHOLICS IN PUERTO RICO AND COSTA RICA J. Serra, A. Villafañe, M. Jiménez, W. Jiménez Universidad de Puerto Rico, San Juan, Puerto Rico.
SEX ADDICTION : PSYCHIATRIC AND PSYCHOTHERAPEUTIC PERSPECTIVES Feldman Nelson, Sophia Ahab, Rodolphe Soulignac, Yasser Khazaal, Daniele Zullino
www.cipd2015.com Pág. 21
th Saturday April 18 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Service d’Addictologie, Département de santé mentale et psychiatrie, University Hospital of Geneva HUG, Switzerland.
COCAINE IMPAIRS CELL GENESIS DURING ADOLESCENCE: IMPLICATIONS FOR DEPRESSION- LIKE BEHAVIOR IN ADULTHOOD M.J. García-Fuster, R. García-Cabrerizo, B. Keller University of the Balearic Islands, Palma de Mallorca, España.
QUALITY OF LIFE OF MEN WITH ALCOHOL DEPENDENCE SYNDROME I. Linnuste1, 2, K. Lang2 1 Foundation Pärnu Hospital, Pärnu, Estonia. 2 University of Tartu, Tartu, Estonia.
THE ROLE OF FAITH, SPIRITUALITY AND RELIGION IN THE PROCESS OF RECOVERY FROM DUAL DISORDERS Susana E. Mendez Enterhealth, Residential and Outpatient Services. Dallas, TE, USA.
IMPLEMENTATION OF AN INTEGRATED CARE PATHWAY FOR CONCURRENT MAJOR DEPRESSIVE DISORDER AND ALCOHOL DEPENDENCE A.V.Samokhvalov1,2, J.A.Irving1, S.Awan1, B. Le Foll1,2, P.Voore1,2 1 Centre for Addiction and Mental Health, Toronto, Ontario, Canada. 2 University of Toronto, Toronto, Ontario, Canada.
THE PREVALENCE OF MENTAL DISORDERS AMONG LESBIAN, GAY, BISEXUAL AND TRANSGENDER (LGBT) IN BAGHDAD Aziz Salim Shakir Fibms Iraqi Ministry of Health, Iraq.
17:00 - 19:00 h.
17:00 – 17:30 OPENING CEREMONY Auditorium
17:30 – 19:00 Plenary Session - PS02 Auditorium BRAIN ADDICTIVE CIRCUITS ARE COMMON TO OTHER MENTAL ILLNESSES Track: Multidisciplinary Chair: Intervention in Dual Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Disorders Marañón. Madrid, España. Speaker: Nora Volkow, National Institute on Drug Abuse (NIDA), Bethesda. MD, USA. 19:00 – 20:30 NETWORKING EVENING Auditorium
www.cipd2015.com Pág. 22
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
08:30 – 10:00 h.
08:30 – 10:00 Symposium – SY24 Auditorium A DIAGNOSTIC AND THERAPEUTIC CHALLENGES IN DUAL ADHD Track: Attention Deficit Chair: Salvador Ros, Hospital del Mar. Universidad Autónoma de Barcelona, España. Speakers: ADHD AND SUBSTANCE USE DISORDER Juan Ramirez, Servicio Provincial Drogodependencias y Adicciones Huelva. España. ADHD AND BEHAVIORAL ADDICTIONS Juncal Sevilla, Universidad Autónoma de Madrid, Fundación Jimenez Díaz. Madrid, España. NEW CHALLENGES IN TREATMENT OF DUAL ADHD Andres Fontalba, Centro Salud Mental de Distrito, Huercal-Olvera. Huelva, España.
08:30 – 09:15 Main Lecture - ML06 Room 1 ROLE OF KAPPA OPIOID RECEPTORS IN THE TREATMENT OF DUAL PATHOLOGY Track: Opioid System Chair: and Dual Disorders Julio Bobes, Universidad de Oviedo, España. Speaker: Iván Montoya, Division of Pharmacotherapies and Medical Consequences of Drug Abuse, NIDA, USA.
09:15 – 10:00 Main Lecture - ML07 Room 1 REVISTING OLD CONCEPTS ON ADULT ADHD Track: Attention Deficit Chair: Luis Alfonzo B., Organización Panamericana de la salud. Washington, USA. Speaker: Luis A. Rohde, Federal University of Rio Grando do Sul, Department of Psychiatry, Porto Alegre, Brasil.
08:30 – 10:00 Symposium - SY25 Room 2-3 DUAL DISORDERS AND FREE WILL Track: Spirituality and Chair: Dual Disorders Célia Franco, Centro Hospitalar Universitário de Coimbra, Portugal. Speakers: DUAL DISORDERS AND FREE WILL. WHAT IS HAPPENING? Luiz C. Coronel, Centro de Estudios Jose de Barros Falcão. Porto Alegre, Brasil. DUAL PATHOLOGY AND MENTAL COMPETENCES, WHAT CHANGES? Alfredo Calcedo, Universidad Complutense de Madrid. Madrid, España.
08:30 – 10:00 Symposium - SY26 Room 4 POTENTIAL THERAPEUTIC USE OF CANNABINOID RECEPTORS AND PHYTOCANNABINOIDS Track: Cannabis and IN DUAL PATHOLOGY Dual Disorders Chair:
www.cipd2015.com Pág. 23
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Jorge Manzanares, Universidad Miguel Hernández. Alicante, España. Speakers: THERAPEUTIC PERSPECTIVES OF CANNABIDIOL (CBD) IN THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS Jorge Manzanares, Universidad Miguel Hernández. Alicante, España. RELEVANCE OF THE REGULATION OF CANNABINOID SYSTEM IN DUAL PATHOLOGY Mª Salud García, Instituto de Neurociencias, Universidad Miguel Hernández. Alicante, España. ROLE OF CANNABINOID CB1 RECEPTOR IN DRUG ADDICTION AND DUAL PATHOLOGY Olga Valverde, Universitat Pompeu Fabra. Barcelona, España.
08:30 – 10:00 Symposium - SY27 Room 5 BIOLOGICAL RHYTHMS AND DUAL DISORDERS. A NON NEGLIGIBLE CONNECTION Track: Multidisciplinary Chair: Intervention in Dual Ana Adan, Instituto de Investigación en Cerebro, Cognición y Conducta de la Universidad de Disorders Barcelona, España. Speakers: CHRONOBIOLOGY AND DUAL DISORDERS. THE CURRENT STATE OF KNOWLEDGE Sílvia López-Vera, Universitat de Barcelona. Barcelona, España. RHYTHMIC IMPAIRMENT AND MODULATING FACTORS IN PATIENTS WITH DUAL DIAGNOSIS Irina Benaiges, Universitat de Barcelona. Barcelona, España. CLINICAL IMPLICATIONS OF RHYTHMIC IMPAIRMENT IN SUBSTANCE USE DISORDERS AND DUAL DIAGNOSIS Ana Adan, Instituto de Investigación en Cerebro, Cognición y Conducta de la Universidad de Barcelona, España.
08:30 – 10:00 Debate Forum - DF09 Room 6 WADD By invitation only Chair: Pedro Ruiz, Department of Psychiatry & Behavioral Sciences, Miller School of Medicine – University of Miami. FL, USA. Co-chairs: Miguel Casas, Universitat Autònoma de Barcelona, Hospital Universitari Vall d’Hebron. Barcelona, España. Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España.
08:30 – 10:00 Invited Symposium – IS07 Room 7 THE OLD COUPLE: COCAINE AND PSYCHOSIS Track: Chair: Psychoestimulants Carlos Roncero, Universidad Autónoma de Barcelona, España. Speakers: GENETIC FEATURES OF COCAINE INDUCED PSYCHOSIS
www.cipd2015.com Pág. 24
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Henry R. Kranzler, Perelman School of Medicine, University of Pennsylvania. Treatment Research Center. PA, USA. EPIDEMIOLOGY OF COCAINE INDUCED PSYCHOSIS Florence Vorspan, Publique-Hôpitaux de Paris, France. PSYCHOPATHOLOGICAL DIFFERENCES BETWEEN COCAINE-INDUCED PSYCHOSIS AND INDEPENDENT PSYCHOSIS IN COCAINE USERS Francisco González-Saiz, Unidad de Salud Mental Comunitaria, Hospital de Jerez, España.
08:30 – 10:00 Symposium – SY28 Room 8 EMOTIONAL DEPENDENCE: A NEW ADDICTION WITHIN THE FRAMEWORK OF DUAL Track: Behavioral DISORDERS? addictions / Gambling Chair: Disorders Francisco Ferre, Hospital Universitario Gregorio Marañón. Madrid, España. Speakers: EMOTIONAL DEPENDENCE VERSUS LOVE ADDICTION Enrique Echeburúa, Facultad de Psicología-Universidad País Vasco. San Sebastián/ Donostia, España. GENDER VIOLENCE AND EMOTIONAL DEPENDENCY Leticia Camarillo, Hospital General Universitario Gregorio Marañón. Madrid, España. SEX ADDICTION: COMORBIDITY WITH DRUGS AND OTHER PATHOLOGIES Josep Mª Farré, Hospital Universitario Quirón-Dexeus. Barcelona, España.
08:30 – 10:00 Medical Educational Room Room 9 Sponsored by the Foundation on Dual Disorders
08:30 – 10:00 Symposium – SY29 Room 10 ORGANIZATION AND RESOURCES FOR DUAL DISORDERS ASSISTANCE Track: Planning, Chair: regulations and Luis Caballero, Hospital Universitario Puerta de Hierro. Madrid, España. resource management Speakers: ORGANIZATION AND RESOURCES FOR DUAL DIAGNOSIS UNIT IN A MENTAL HOSPITAL IN LATIN AMERICA IN THE LAST CENTURY Elvia Velásquez, Alad (Latinoamerican Association On Addiction), Colombia. RESOURCES AND ORGANIZATION FOR DUAL PATHOLOGY ASSISTANCE IN ITALY Massimo Clerici, Universidad di Milano. Milano, Italy. RESOURCES AND PROCESS CHANGES IN DEMAND OF A CENTRE FOR ADDICTION AND MENTAL DISORDERS IN CUENCA ECUADOR Saul Pacurucu, Centro de Recuperación de Adicciones Cuenca, Universidad de Cuenca, Ecuador.
08:30 – 10:00 Invited Symposium - IS08 Room 11 IMPULSIVITY: A KEY SYMPTOM OR A KEY TREAT IN DUAL DISORDERS? Track: Impulsivity Chair: Rodrigo Cordoba, Grupo CISNE, Bogotá, Colombia. Speakers:
www.cipd2015.com Pág. 25
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
DUAL PATHOLOGY AND COMPULSIVE IN-TAKES Gabriel Rubio, Universidad Complutense de Madrid, España. INFLUENCE OF IMPULSIVITY IN SUICIDE ATTEMPTS, DRIVING ACCIDENTS AND SEVERITY OF ADDICTIONS Laia Rodríguez-Cintas, CAS Vall d'Hebron, Hospital Universitari Vall d'Hebron. Barcelona, España. INFLUENCE OF IMPULSIVITY IN DUAL ADHD Eugenio Grevet, Federal University of Rio Grande do Sul (UFRGS). Porto Alegre Clinical Hospital. Porto Alegre, Brasil.
08:30 – 10:00 Oral Communications - OC05 Room 12 Chairs: Rocío Molina, Centro de Atención a las Drogodependencias de Arganzuela. Madrid, España. Nelson Feldman, HUG Hôpitaux Universitaires de Genève, Switzerland.
LOW-DEMAND TREATMENT IN DUAL DISORDERS R. Fernández López 1, P. Sanz Asín 1,2, A. Bruguera Guitart 1,3, D. Aránega Guizán 1, M. Coromina Gimferrer 1,3, S. Martí Climent1, G. López Cano 1, M.T. Bello Mayoraz1 1 CAS Baluard, Barcelona, España. 2 CAS Sants, Barcelona, España. 3 CAS Sarrià, Barcelona, España.
ABORDAJE Y MANEJO DE LA DINÁMICA FAMILIAR EN LA PATOLOGÍA DUAL Lucas García Thuring1, Mª Nieves Gómez Llano2, Soledad Marzo Pons3 1 CTD El ALba. JCCM. España. 2 Ayuntamiento San Sebastian de los Reyes. Madrid, España. 3 Ayuntamiento de Madrid. España.
THE EFFECT OF PRESCRIBING METHADONE ON CHANGING OF MOODS IN OPIUM ADDICTS Alireza Homayouni1, Seyed Jalal Mosavi Amiri2, Arsalan KhanmohammadiOtaghsara3, Gholamali Nikpour4 1 College of psychology, Bandargaz Branch, Islamic Azad University, Bandargaz, Iran. 2 Medical Clinic of Dr. Mosavi, Amirkola, Iran. 3 College of psychology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran. 4 Allameh Tabatabaii University, Tehran, Iran.
ADDICTION, TRAUMA, MENTAL ILLNESS- TREATMENT OPTIONS FOR COMPLEX CONCURRENT DISORDERS Reinhard Michael Krausz University of British Columbia (UBC). NY, USA.
MULTIDISCIPLINARY RESIDENTIAL INTERVENTION IN DUAL DISORDER E. Muscas, G. Trincas, P. Pili, G. Sanna, G. Grillo Casa Emmaus, Iglesias, Italia.
www.cipd2015.com Pág. 26
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
A TRANSDIAGNOSTIC THERAPY FOR BEHAVIORAL DYSREGULATION: MINDFULNESS AND MODIFICATION THERAPY CUSTOMIZED FOR ALCOHOL USE, DRUG USE, AND ANGER ISSUES P. Wupperman1,2, A.L. Reed1, E. Edwards1, R. Shapiro1, Q. Li1, F. Unachukwa1, B. Ryan1 1 John Jay College/City University of New York, New York, New York, USA. 2 Yale University Medical Center, New Haven, Connecticut, USA.
A DRUG TREATMENT PROGRAM FOR YOUNG ISRAELI BACKPACKERS WHO SUFFER FROM DUAL DIAGNOSIS Hagit Bonny-Noach1, Haim Mell2 1 Ariel University & Beit Berl Academic College- Israel. Consultant, Israel Anti- Drug Authority (IADA). Board Member- Israeli society of Addiction Medicine(ILSAM), Israel. 2 Head, Treatment & Rehabilitation Division, Israel Anti-Drug Authority, Israel.
HOSPITALISATION OF SERVICE USERS BEFORE AND AFTER ADMISSION TO ASSERTIVE COMMUNITY TREATMENT IN NORWAY – DOES SUBSTANCE USE MATTER? H. Clausen1, T. Ruud1, K.S. Heiervang1, S. Odden2, H.K. Stuen2, A. Landheim2 1 Akershus University Hospital, Lørenskog, Norway. 2 National Centre for Dual Diagnosis, Innlandet Hospital Trust, Hamar, Norway.
NALMEFENE IN ALCOHOL USE DISORDER: A PRELIMINARY STUDY L.A. Núñez Domínguez1, M García Nicolás2, O Arbeo Ruiz3 1 Centro Médico, Pamplona, Navarra, España. 2 Mental Health Center, Tudela, Navarra, España. 3 Centro de Día Zuría, Pamplona, Navarra, España.
10:00 – 12:00 h.
10:00 – 12:00 SATELLITE Symposium Room 1 Industry Session not included in official scientific programme CME/CPD
10:00 – 12:00 SATELLITE Symposium Room 2-3 Industry Session not included in official scientific programme CME/CPD
10:00 – 12:00 SATELLITE Symposium Room 6 Industry Session not included in official scientific programme CME/CPD
12:00 – 15:00 h.
12:00 – 13:30 Symposium – SY30 Auditorium A MULTIMODAL APPROACHES FOR ADHD AND DUAL DISORDERS Track: Multidisciplinary Chair: Intervention in Dual Vicent Balanzá, La Fe University and Polytechnic Hospital, University of Valencia, CIBERSAM.
www.cipd2015.com Pág. 27
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Disorders Valencia, España. Speakers: NON-PHARMACOLOGICAL INTERVENTIONS IN CHILDREN AND ADOLESCENTS WITH ADHD Maite Ferrin, The Huntercombe Hospital Maidenhead, Institute of Psychiatry London. London, United Kingdom. THE EFFICACY AND LIMITATIONS OF PHARMACOLOGICAL MANAGEMENT OF ADULT ADHD AND DUAL DISORDERS Eugenio H. Grevet, Federal University of Rio Grande Do Sul (UFRGS). Porto Alegre Clinical Hospital. Porto Alegre, Brasil. THE EXPANDING ROLE OF NUTRITIONAL PSYCHIATRY AND LIFESTYLE MEDICINE FOR BIPOLAR DISORDERS Vicent Balanzá, La Fe University and Polytechnic Hospital, University of Valencia, CIBERSAM. Valencia, España. INTEGRATED BIOPSYCHOSOCIAL-SPIRITUAL TREATMENT FOR ADDICTIONS AND CO- OCCURRING DISORDERS Gregory Bunt, International Society of Addiction Medicine, NYU School of Medicine. NY, USA.
12:00 – 12:45 Main Lecture - ML08 Room 1 DUAL DISORDERS AND MENTAL DISORDERS Track: Multidisciplinary Chair: Intervention in Dual Carmen Leal, Facultad De Medicina De Valencia. Comunitat Valenciana, España. Disorders Speaker: Julio Sanjuan, Universitat de Valencia. Comunitat Valenciana, España.
12:45 – 13:30 Main Lecture - ML09 Room 1 UPDATE: PSYCHOPATHY IN DUAL PATHOLOGY Track: Personality Chair: Disorders Miguel Casas, Universitat Autònoma de Barcelona, Hospital Universitari Vall d’Hebron. Barcelona, España. Speaker: Rafael Torrubia, Universidad Autónoma de Barcelona. Barcelona, España.
12:00 – 14:00 Debate Forum – DF10 Room 2-3 WPA SECTION ON DUAL DISORDERS By invitation only Chair: Pedro Ruiz, Department of Psychiatry & Behavioral Sciences, Miller School of Medicine – University of Miami. FL, USA. Co-chairs: Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España. Javier Didia, Hospital Italiano de Buenos Aires y Universidad de Buenos Aires, Argentina. Nady El-Guebaly, University of Calgary. Alberta, Canada.
12:00 – 13:30 Symposium – SY31
www.cipd2015.com Pág. 28
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Room 4 RESEARCH IN NEUROBIOLOGY AND CLINICAL TRIALS REGARDING DISORDERS DUE TO Track: Cannabis and CANNABIS ABUSE AND IN PSYCHOEDUCATIONAL GROUP THERAPY FOR PATIENT’S Dual Disorders FAMILIES Chair: Josep Solé, Centre D'Atenció I Seguiment De Drogodependències Benito Menni. Barcelona, España. Speakers: NEUROPSYCHOLOGICAL DISORDERS ASSOCIATED WITH CANNABIS USE Laura Blanco, Centre D'Atenció I Seguiment De Drogodependències Benito Menni. Barcelona, España. DATA FROM CLINICAL RESEARCH CANNABIS ADDICTION Begoña Gonzalvo, Centre D'Atenció I Seguiment Sant Boi Llobregat. Benito Menni CASM. Barcelona, España. PSYCHOEDUCATIONAL GROUP THERAPY AIMED AT FAMILY MEMBERS OF PEOPLE WITH SUBSTANCE DEPENDENCE DISORDER LINKED TO A DRUG ADDICTION CENTER Alfredo Felices de la Fuente, Centre D'Atenció I Seguiment Sant Boi Llobregat. Benito Menni CASM. Barcelona, España.
12:00 – 13:30 Symposium - SY32 Room 5 NEW PSYCHOACTIVE DRUGS: APPROACH, PERSPECTIVES AND PSYCHOPATHOLOGY Track: Multidisciplinary Chair: Intervention in Dual Helen Dolengevich, Hospital Universitario Del Henares. Madrid, España. Disorders Speakers: MEDICAL APPROACH TO THE INTOXICATED PATIENT. WHAT NEEDS TO CHANGE? Daniel Sánchez, Hospital Universitario La Fe. Valencia, España. NEWEST PSYCHOACTIVE DRUGS ON THE NET Jorge Gómez-Arnau, Hospital Universitario Del Henares. Madrid, España. SYNTHETIC CANNABINOIDS AND PSYCHOPATHOLOGY: PSYCHOSIS IN THE SPOTLIGHT Carlos Parro, C.S. Mental Retiro. Hospital Universitario Gregorio Marañón. Madrid, España.
12:00 – 13:30 Invited Symposium – IS09 Room 6 EPIDEMIOLOGY Track: Epidemiology Chair: and Dual Disorders Josep Mª Haro, Hospital San Joan de Deu. Barcelona, España. Speakers: EPIDEMIOLOGY OF ALCOHOL CONSUMPTION IN DUAL PATIENTS Teresa Brugal, Agencia de Salut Pública Barcelona. Barcelona, España. GENDER DIFFERENCES IN PACIENTS WITH DUAL ALCOHOLISM Jesús Perez Pazos, Centre d'Atenció I Seguiment de Drogodependències Vall d'Hebron. Barcelona, España. ALCOHOL CONSUMPTION IN ADOLESCENTS IN DUAL PATHOLOGY Rodrigo Córdoba, Centro de Investigaciones del Sistema Nervioso (Grupo Cisne). Bogotá, Colombia.
www.cipd2015.com Pág. 29
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
12:00 – 13:30 Symposium - SY33 Room 7 ATTENTION TO ADOLESCENTS AND YOUNG ADULTS IN THE INSTITUTE OF ADDICTIONS Track: Child & MADRID SALUD. CHALLENGE IN THE INTERVENTION OF DUAL PATHOLOGY Adolescent Psychiatry Chair: Antonio Prieto, Madrid Salud (Salud Pública del Ayuntamiento de Madrid), España. Speakers: DOES THE PROCESS MANAGEMENT INCREASE THE QUALITY AND EFFICIENCY IN THE CARE OF ADOLESCENTS WITH PROBLEMS OF ADDICTION? Mª Teresa Pérez, Instituto de Adicciones de Madrid. Madrid, España. INTERVENTION WITH ADOLESCENTS WITH DUAL DIAGNOSIS FROM A DEPENDENCE ADDICTION CENTER Marina Delgado, Instituto de Adicciones de Madrid. Madrid, España. TREATMENT OF ADOLESCENTS AND YOUNG ADULTS IN A SPECIFIC THERAPEUTIC RESOURCE Pedro Pablo Herraiz, Instituto de Adicciones de Madrid. Madrid, España.
12:00 – 13:30 Symposium - SY34 Room 8 PSYCHOSIS AND PSYCHOACTIVE SUBSTANCES: AN EVER CHANGING SCENARIO Track: Psychosis Chair: Giovanni Martinotti, University "G.D'Annunzio", Chieti, Italy. Speakers: COCAINE INDUCED PSYCHOTIC DISORDERS AND PSYCHOTIC SYMPTOMS IN COCAINE DEPENDENT PATIENTS Carlos Roncero, Universidad Autónoma de Barcelona, España. THE LYSERGIC PSYCHOMA Giovanni Martinotti, University "G.D'Annunzio", Chieti, Italy. PSYCHOTIC EXPERIENCES AND SUBSTANCE ABUSE: THE CLUB SCENE IN IBIZA Cristina Merino del Villar, Hospital Can Misses. Ibiza, España. SYNTHETIC CANNABINOIDS AND "SPICEOPHRENIA" Rita Santacroce, University "G.D'Annunzio", Chieti, Italy. Duccio Papanti, University of Trieste, Trieste, Italy.
12:00 – 13:30 Medical Educational Room Room 9 Sponsored by the Foundation on Dual Disorders
12:00 – 13:30 Symposium - SY35 Room 10 DEVELOPMENT OF A NOVEL IN-PATIENT SERVICE MODEL AND PROGRAM FOR DUAL Track: Planning, DISORDERS regulations and Chair: resource management Bridin Murnion, Sydney Local Health District. Sydney, Australia. Speakers: DEVELOPING A MODEL OF CARE FOR COMPLEX CO-MORBIDITY-A SYSTEMS PERSPECTIVE Bridin Murnion, Sydney Local Health District. Sydney, Australia. STAGE 3 CLIENTS PROGRAM Danielle Florida, Concord Hospital. Concord, NSW, Australia.
www.cipd2015.com Pág. 30
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
STAGE 2 CLIENTS PROGRAM Lisa Juckes, Concord Hospital. Concord, NSW, Australia. DEVELOPING A MODEL OF CARE FOR COMPLEX CO-MORBIDITY-THE PATIENT AND STAFF PERSPECTIVE Wendy Kerley, Concord Hospital. Concord, NSW, Australia.
12:00 – 12:45 Workshop - WS08 Room 11 ADOLESCENT TO PARENT VIOLENCE IN ADOPTED AND NON-ADOPTED TEENAGERS AND Track: Evaluation YOUNG ADULTS WITH DUAL DISORDERS: A COMPARATIVE DIAGNOSTIC STUDY processes in Dual Chair: Disorders Jordi Royo, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y sus Familias. Barcelona, España. Speakers: DIAGNOSTIC CRITERIA FOR ADOLESCENT TO PARENT VIOLENCE IN ADOPTED AND NON- ADOPTED TEENAGERS AND YOUNG ADULT PATIENTS Jordi Royo, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y sus Familias. Barcelona, España. COMPARATIVE DIAGNOSTIC STUDY IN ADOPTED AND NON-ADOPTED TEENAGERS AND YOUNG ADULTS WITH CHILD TO PARENT VIOLENT BEHAVIOUR M. Àngels Feliu, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y sus Familias. Barcelona, España.
12:45 – 13:30 Workshop – WS09 Room 11 MINDFULNESS FOR TREATING DUAL DISORDERS Track: Chair: Psychotherapeutic Rosa Tejedor, Centro de Atención Drogodependencias. Fundacion Althaia. Xarxa Assitencial Treatment in Dual Universitaria de Manresa. Barcelona, España. Disorders Speakers: MINDFULNESS FOR TREATMENT TO SUBSTANCE USE DISORDERS Rosa Tejedor, Centro de Atención Drogodependencias. Fundacion Althaia. Xarxa Assitencial Universitaria de Manresa. Barcelona, España. MINDFULNESS IN RELAPSE PREVENTION Antonia Raich, Althaia Xarxa Assistencial Universitaria Manresa. Barcelona, España.
12:00 – 13:30 Oral Communications - OC06 Room 12 Chairs: Enriqueta Ochoa, Hospital Ramón y Cajal de Madrid, España. Luis Patricio, Casa de Saude de Carnaixade. Carnaixade, Portugal.
TRANSLATING EXPERIMENTAL FINDINGS INTO THE CLINICAL CONSULTING ROOM: A CASE EXAMPLE Cynthia Cabral City College of New York, City University of New York, NY, USA. St. John’s University, Queens, USA.
www.cipd2015.com Pág. 31
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
CANNABINOID HYPEREMESIS SYNDROM. A REPORT OF SIX NEW CASES AND A RESUME OF PREVIOUS REPORTS C. Contreras Narváez¹, M. Mola Gilbert², E. Batlle de Santiago², E. Giné Serven¹, J. Bigas Farreres³ 1 Departamento de Salud Mental. Hospital de Mataró. Barcelona, España. 2 Centro de atención a las drogodependencias. Hospital de Mataró. Barcelona, España. 3 Servicio de Urgencias. Hospital de Mataró. Barcelona, España.
CHANGES IN BODY WEIGHT AMONG BIPOLAR PATIENTS PARTICIPATING IN A RANDOMIZED, PLACEBO-CONTROLLED TRIAL (RCT) OF VARENICLINE FOR SMOKING CESSATION De Matteis M1.2, Clinebell K2, Rai A3; Chengappa KNR2 1 Hospital General Universitario Gregorio Marañon, Madrid, España. 2 UPMC, Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA. 3 St. Mary's Mercy hospital, Livonia, MI, USA.
EFFECTS ON BRAIN FUNCTION OF USE OF MARIJUANA IN SCHOOLBOYS EVIDENCED BY NEUROPSYCHOLOGICAL TESTING SHOWN BY NEURO-SPECT IMAGES Ismael Mena2, Anneliese Dörr1, Sandra Viani2, Sonia Neubauer2, María Elena Gorostegui1, María Paz Dörr1, Diana Ulloa3 1 Facultad de Medicina, Universidad de Chile, Chile. 2 Clínica Las Condes, Santiago, Chile. 3 Facultad de Ciencias Sociales, Universidad de Chile, Chile.
MARIJUANA TEEN CONSUMERS: IMPLICATIONS FOR FAMILY AND SCHOOL Anneliese Dörr, M. Elena Gorostegui, Sandra Viani, M. Paz Dörr B. 1 Universidad de Chile, Facultad de Medicina, Santiago de Chile, Chile. 2 Universidad Católica de Chile, Facultad de Psicología, Santiago de Chile, Chile. 3 Hospital Clínico, Universidad Católica de Chile, Santiago de Chile, Chile.
PALIPERIDONE PALMITATE. AN EXPERIENCE IN DUAL PATHOLOGY R. Salmons Aleu, T. Borràs Cabacés Hospital Universitario S. Joan, Reus, Tarragona, España.
FAMILIAL FACTORS ASSOCIATED WITH DEVELOPMENT OF ALCOHOL AND MENTAL HEALTH COMORBIDITY C.L. Salom, G.M. Williams, J.M. Najman, R. Alati University of Queensland, Brisbane, Australia.
SEX DIFFERENCES IN THE EFFECTS OF IMMUNE ACTIVATION DURING THE GESTATIONAL STAGE ON COCAINE SELF-ADMINISTRATION IN ADULTHOOD: PRELIMINARY DATA FROM A MODEL OF DUAL DIAGNOSIS R. Santos-Toscano, D. Roura-Martínez, M. Ucha-Tortuero, MA. Assís, M. Miguéns, E. Ambrosio, A. Higuera-Matas UNED. Madrid, España.
www.cipd2015.com Pág. 32
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
RELATIONSHIP BETWEEN CANNABIS AND PSYCHOSIS: DANGEROUS LINK? Nelson Feldman, Daniele Zullino, Yasser Khazaal, Logos Curtis Hôpitaux Universitaires de Genève, Switzerland.
13:30 – 15:00 Invited Symposium - IS10 Auditorium A ADHD AS A CAUSAL FACTOR IN DUAL DISORDERS Track: Attention Deficit Chair: Miquel Roca, Universidad de las Islas Baleares. Mallorca, España. Speakers: GENETIC RISK FOR ADHD IN ADDICTED PATIENTS Josep A. Ramos Quiroga, Hospital Universitari Vall d'Hebron. Barcelona, España. INFLUENCE OF ADHD IN ADDICTION EVOLUTION Frances Levin, New York Presbiterian Hospital, NYS Psychiatric Institute. NY, USA. NEED OF TREATMENT IN DUAL ADHD José Martínez-Raga, Unidad de Conductas Adictivas de Gandia, CEU Cardenal Herrera. Valencia, España.
13:30 – 15:00 Invited Symposium - IS11 Room 1 SHARED VULNERABILITY TO DUAL DISORDERS, PSYCHOSIS AND CANNABIS ADDICTIONS Track: Psychosis Chair: Julio Vallejo, Universidad de Barcelona, España. Speakers: CANNABIS IN FIRST EPISODE PSYCHOTIC PATIENTS Miquel Bernardo, Hospital Clínico. Universitat de Barcelona, España. NEUROIMAGING IN DUAL DISORDER PATIENTS CONSUMERS OF CANNABIS Benedicto Crespo- Facorro, Hospital Universitario Marqués de Valdecilla. Santander, España. FOLLOW UP, CANNABIS IN-TAKE AND THE PSYCHOSIS EVOLUTION Ana González Pinto, Hospital Santiago Apóstol. Vitoria, España.
13:30 – 15:00 Symposium – SY36 Room 4 THINGS TO KNOW OF CANNABIS CONSUMPTION IN DUAL PATIENTS Track: Cannabis and Chair: Dual Disorders Mercedes Balcells, Hospital Clínic I Universitari De Barcelona. Barcelona, España. Speakers: INSTRUMENTS FOR ASSESSING CANNABIS USE IN PSYCHIATRIC PATIENTS Hugo López-Pelayo, Grup de Recerca En Addicions Clínic. Hospital Clínic i Universitari de Barcelona. Barcelona, España. COGNITIVE IMPAIRMENT IN CANNABIS USERS: FROM RESEARCH TO CLINICAL PRACTICE Albert Batalla-Cases, Tactus Addiction Treatment. Deventer, The Netherlands. CANNABINOID HYPEREMESIS SYNDROME: EPIDEMIOLOGY, ASSESSMENT AND DIFFERENTIAL DIAGNOSIS Laia Miquel, Grup de Recerca en Addicions Clínic. Hospital Clínic i Universitari de Barcelona. Barcelona, España.
www.cipd2015.com Pág. 33
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
PSYCHOACTIVE COMPONENTS OF CANNABIS AND THEIR CLINICAL IMPLICATIONS Cristina Casajuana, Grup De Recerca En Addicions Clínic. Hospital Clínic i Universitari de Barcelona. Barcelona, España.
13:30 – 15:00 Invited Symposium – IS12 Room 5 FOOD AND DRUGS: BINGE-EATING DISORDERS Track: Eating Disorders Chair: Ignacio Basurte, Hospital General Universitario Gregorio Marañón. Madrid, España. Speakers: IS EATING DISORDER AN ADDICTIVE DISORDER? Luis Rojo Moreno, Hospital Universitario y Politécnico La Fe. Valencia, España. Luis Rojo Bofill, Servicio de Psiquiatría. HU La Fe, Valencia, España. IS BINGE EATING DISORDER AN EVOLUTION OF THE ADDICTION? Francisco J. Vaz, Complejo Hospitalario Universitario UNEX. Badajoz, España. SYMPTOMS OF ADHD IN ED AS A RISK FACTOR FOR DD Marina Díaz Marsá, Hospital Clínico San Carlos. Madrid, España.
13:30 – 15:00 Symposium – SY37 Room 6 CARE PATTERNS IN DUAL PATHOLOGY. NEARING ITS EFECTIVENESS AND EFFICIENCY Track: Planning, THROUGH THE FOLLOW UP OF PATIENTS? regulations and Chair: resource management Indalecio Carrera, Asociación Ciudadana de Lucha contra la Droga (ACLAD). A Coruña, España. Speakers: SPECIFIC INTERVENTIONS IN THE UPD OF COIMBRA Carla Torres, Unidade de Patologia Dual, Centro Hospitalar Universitário de Coimbra, Portugal. DUAL PATHOLOGY IN ADDICTION NETWORKS OF HEALTH AREAS IN PORTO AND CORUÑA José A. Santos, Serviço de Intervenção nos Comportamentos Aditivos e nas Dependências (SICAD), Portugal. THE DUAL PATHOLOGY IN MENTAL HEALTH NETWORK IN LA CORUÑA Mª Carmen García, Complejo Hospitalario Universitario de A Coruña, Universidad de Santiago de Compostela. Galicia, España. ANALYSIS OF CARE MODELS AND PROPOSALS FOR IMPROVING THEIR QUALITY Indalecio Carrera, Asociación Ciudadana de Lucha contra la Droga (ACLAD). A Coruña, España.
13:30 – 15:00 Symposium - SY38 Room 7 CARE PROGRAM FOR SICK PHYSICIANS: HEALTH AND QUALITY INTERVENTION Track: Sick Doctors Chair: and Dual Disorders Mar Sánchez, Servicio de Psiquiatría del Hospital General Universitario de Ciudad Real. Castilla la Mancha, España. Speakers: PAIME REPORT. FUTURE WORK LINES Mar Sánchez, Servicio de Psiquiatría del Hospital General Universitario de Ciudad Real.
www.cipd2015.com Pág. 34
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Castilla la Mancha, España. THE PSYCHOLOGIST ROLE IN PAIME. INTERVENTION STRATEGIES BASED ON MEDICAL ASSOCIATIONS Isabel Montoya, Psicologa Clinica del PAIME de Ciudad Real. Castilla la Mancha, España. PATIENT PAIME: DESIGN SOCIAL PROTECTION Nina Mielgo, Fundación Protección Social Médicos Príncipe de Asturias. Oviedo, España.
13:30 – 15:00 Symposium – SY39 Room 8 GAMBLING DISORDERS AND PSYCHOTIC DUAL DISORDERS (SCHIZOPHRENIA) Track: Behavioral Chair: addictions / Gambling Enrique Echeburúa, Facultad de Psicología-Universidad País Vasco. San Sebastián/ Donostia, Disorders España. Speakers: PSYCHIATRIC COMORBIDITY ASSOCIATED WITH PATHOLOGICAL GAMBLING Enrique Echeburúa, Facultad de Psicología-Universidad País Vasco. San Sebastián/ Donostia, España. CLINICAL AND PSYCHIATRIC IMPLICATIONS OF PATHOLOGICAL GAMBLING IN SCHIZOPHRENIA Gemma Parramon, Hospital Universitari Vall d'Hebron. Barcelona, España. PSYCHOLOGICAL IMPLICATIONS OF SCHIZOPHRENIA IN PATHOLOGICAL GAMBLING. Montserrat Gómez, Asociación Barcelonesa de Ludopatía y Adicciones/ Instituto de Diagnostico Psicológico, Barcelona, España.
13:30 – 15:00 Medical Educational Room Room 9 Sponsored by the Foundation on Dual Disorders
13:30 – 15:00 Symposium – SY40 Room 10 TREATMENT SYSTEMS/SERVICES FOR DUAL DISORDERS: EXPERIENCES IN DIFFERENT Track: Planning, COUNTRIES regulations and Chair: resource management Christian G. Schütz, University of British Columbia. Vancouver, Canada. Co-chair: Marta Torrens, Institut de Neuropsiquiatria I Addiccions-Parc de Salut Mar, Universitat Autònom, Barcelona, España. Speakers: THE TREATMENT OF DUAL DISORDER PATIENTS IN SWITZERLAND Lola Peris, Centre de Neuchâtelois de Psychiatrie (CNP) Neuchàctel, Switzerland. THE RESTRUCTURING OF DUAL DIAGNOSES HEALTH CARE IN THE BRITISH COLUMBIA, CANADA: IS THE PATH THE GOAL? Christian G. Schütz, University of British Columbia. Vancouver, Canada. CONTRASTING DUAL DIAGNOSES APPROACHES IN AUSTRALIA TO APPROACHES IN OTHER CONTINENTS Enrico Cementon, University of Melbourne. Melbourne VIC, Australia.
13:30 – 14:15 Workshop - WS10
www.cipd2015.com Pág. 35
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Room 11 DUAL DISORDERS AND LIBERALISM Track: Cannabis and Chair/ Speaker: Dual Disorders Susana E. Méndez, Enterhealth, Residential and Outpatient Services, Dallas TX, USA.
14:15 – 15:00 Workshop - WS11 Room 11 COGNITIVE-AFFECTIVE MECHANISMS INVOLVED IN THE INTERPRETATION OF DRUG USE IN Track: DUAL DISORDERS Psychotherapeutic Chair: Treatment in Dual Humberto Guajardo, Universidad de Santiago de Chile. Santiago de Chile, Chile. Disorders Speakers: POSRACIONALISTIC PERSPECTIVE IN DUAL PATHOLOGY Humberto Guajardo, Universidad de Santiago de Chile. Santiago de Chile, Chile. INTERPRETATED EFFECT ON DRUG ABUSE Diana Kushner, Universidad de Santiago de Chile. Santiago de Chile, Chile.
13:30 – 15:00 Oral Communications – OC07 Room 12 Chairs: Carolina Franco, Centre d´Higiene Mental Les Corts. Barcelona, España. Enrique Mendoza, Asociación Psiquiátrica de América Latina (APAL), Guatemala.
HIGHER FREQUENCY OF C.3435 OF THE ABCB1 GENE IN PATIENTS WITH TRAMADOL DEPENDENCE DISORDER Dalia Enaba1, Heba El Baz1, Hamdy Moselhy2 1 Psychiatry Department and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt. 2 Medicine, UAE University, Al Ain, United Arab Emirates.
THE BINOMIAL VIOLENCE AND ALCOHOL P.M. Fuertes Psychology. Astorga. León, España.
THE ASSOCIATION BETWEEN GRIT AND DUAL DIAGNOSIS AMONG INPATIENTS WITH ALCOHOL USE DISORDERS M.L. Griffin1,2; R.D. Weiss 1.2 1 Harvard Medical School, Boston, Massachusetts, USA. 2 Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, Massachusetts, USA.
ENERGY DRINKS: AN EMERGING HEALTH PROBLEM Sara Meca Zapatero Centro G. SINadicciones, (Gabinete Psicológico especializado en la Prevención y Rehabilitación de Conductas Adictivas, Psicología Clínica y Patología Dual) Valencia, España.
DETOXIFICATION WITH METHADONE FOR THE TREATMENT OF PRESCRIPTION OPIOID USE DISORDER: TWO CLINICAL CASES
www.cipd2015.com Pág. 36
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Oriolo G1, Barrio P1, Balcells M1,2 1 Institut Clínic of Neuroscience (ICN). Hospital Clínic de Barcelona, Catalonia, España. 2 Institut d’Investigacions Biomédiques August Pi i Sunyer (IDIBAPS). España.
BACLOFEN : MAINTENANCE OF ABSTINENCE IN ALCOHOL DEPENDENT PATIENTS ATTENDING LIVER CLINIC Lynn Owens1, Abi Rose2, Andrew Thompson2, Ian Gilmore1, Munir Pirmohamed2, Paul Richardson1 1 Royal Liverpool Hospital Trust. United Kingdom. 2 University of Liverpool. United Kingdom.
DUAL PATHOLOGY ON ALCOHOLIC PEOPLE: A DESCRIPTIVE STUDY M.A. García Carretero1, M. Robles Martínez2, M.A. Jordán Quintero3, J. Gibert Rahola4 1 CTS391 Grupo Multidisciplinar para el progreso de la Salud Mental, Universidad de Cádiz, España. 2 CTA ARCA y Hospital Universitario Puerta del Mar, Cádiz, España. 3 Hospital Universitario Puerta del Mar, Cádiz, España. 4 CTA ARCA y Departamento Neurociencias, Universidad de Cádiz, España.
INJECTION AND NON INJECTION DRUG USERS PRESENTING IN A TEACHING HOSPITAL IN SOKOTO, NIGERIA. A REPORT OF SOCIOCULTURAL FACTOR AS BARRIER IN MANAGEMENT M.A. Yunusa 1,2, A. Obembe 1,2 1 Usman Danfodiyo University, Sokoto, Nigeria. 2 Usman Danfodiyo University Teaching Hospital, Sokoto, Nigeria.
DIFFERENCES BETWEEN OPIATE AND NON-OPIATE USING POPULATIONS: CHARACTERISTICS, MOTIVATION, RETENTION AND OUTCOMES IN DUAL DIAGNOSIS TREATMENT Siobhan A. Morse Foundations Recovery Network in Nashville, Tennessee, USA.
15:00 – 16:30 h.
15:00 – 15:45 Main Lecture – ML10 Auditorium A ADHD AND ADDICTIONS, A PATTERN OF DUAL DISORDERS Track: Basic Research Chair: Francisco de Asís Babín, Plan Nacional Sobre Drogas, España. Speaker: Nora Volkow, National Institute on Drug Abuse (NIDA), Bethesda. MD, USA.
15:45 – 16:30 Main Lecture – ML11 Auditorium A NEW PHARMACOLOGICAL APPROACHES IN ADHD AND DUAL DISORDERS Track: Attention Deficit Chair: Carlos Mur, Hospital Psiquiátrico José Germain, Leganés, España.
www.cipd2015.com Pág. 37
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Speaker: Frances Levin, New York Presbiterian Hospital, NYS Psychiatric Institute. NY, USA.
15:00 – 16:30 Invited Symposium - IS13 Room 1 THE HOUSE IS ON FIRE: GAMBLING DISORDERS AND DUAL PATHOLOGY Track: Behavioral Chair: Addictions / Gambling Francisco Ferre, Hospital Universitario Gregorio Marañón. Madrid, España. Disorders Speakers: INTERNET USE AND DUAL DISORDER Marc Auriacombe, Faculté de Médecine, Université de Bordeaux, France. GAMBLING RISKS AND DUAL DISORDERS Nady El-Guebaly, University of Calgary. Alberta, Canada. ADDICTION TO ‘SMART PHONE’ Mariano Choliz, Universidad de Valencia, España.
15:00 – 16:30 Symposium – SY41 Room 2-3 RIOD: EMERGING NEEDS IN DUAL PATHOLOGY IN DEVELOPING IBEROAMERICAN Track: COUNTRIES Psychotherapeutic Chair: Treatment in Dual Javier Didia, Hospital Italiano de Buenos Aires y Universidad de Buenos Aires, Argentina. Disorders Co-chair: Mar Sánchez, Servicio de Psiquiatría del Hospital General Universitario de Ciudad Real. Castilla la Mancha, España. Speakers: PRESENTATION OF RIOD (RED IBEROAMERICANA DE DROGODEPENDENCIAS) Felisa Pérez, Red Iberoamericana de Drogodependencias, Madrid, España. Javier Didia, Hospital Italiano de Buenos Aires y Universidad de Buenos Aires, Argentina.
15:00 – 16:30 Symposium – SY42 Room 4 CANNABIS, CANNABINOIDS AND DUAL PSYCHIATRIC DISORDERS Track: Cannabis and Chair: Dual Disorders Shaul Lev-Ran, Sheba Medical Center. Tel Hashomer, Israel. Speakers: A LONGITUDINAL EXPLORATION OF THE IMPACT OF CANNABIS USE ON INCIDENCE AND COURSE OF ILLNESS OF MOOD DISORDERS Shaul Lev-Ran, Sheba Medical Center. Tel Hashomer, Israel. CLINICAL CHARACTERISTICS OF HOSPITALIZED SYNTHETIC CANNABINOID USERS Gal Shoval, Geha Mental Health Center, Tel Aviv University. Tel Aviv, Israel. CANNABIS USE AND HALLUCINOGEN PERSISTING PERCEPTION DISORDER: A CASE SERIES Arturo Lerner, Lev- Hasharon MHC, Sackler School of Medicine Tel Aviv University. Tel Aviv, Israel.
15:00 – 16:30 Symposium – SY43 Room 5 DRUG USE HAS NO AGE LIMIT. DUAL PSYCHOPATHOLOGY AND INTEGRATED TREATMENT Track: Multidisciplinary APPROACH IN OLD-AGE
www.cipd2015.com Pág. 38
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Intervention in Dual Chair: Disorders Antonio Bulbena, Parc de Salut Mar, Universitat Autònoma de Barcelona. Barcelona, España. Speakers: PSYCHOPATHOLOGY IN GERIATRICS Manuel Sánchez, Unidad de Psiquiatría Geriátrica, Hospital Sagrat Cor Martorell. Barcelona, España. INTEGRATED APPROACH TO THE ELDERLY PATIENT Ángel Moríñigo, Psiquiatra Ejercicio Privado. Sevilla, España. DRUG USE HAS NO AGE LIMIT Elena Ros-Cucurull, Hospital Universitari Vall d’Hebron. Barcelona, España.
15:00 – 16:30 Symposium – SY44 Room 6 CLINICAL IMPLICATIONS OF ALCOHOL CONSUMPTION: INFLUENCE OF DUAL PATHOLOGY Track: Alcohol Chair: Nelson Feldman, HUG Hôpitaux Universitaires de Genève, Switzerland. Speakers: ALCOHOL USE AND OPIATE DEPENDENCE Jean-Pierre Daulouede, Centre Hospitalier de la CA'te Basque, Bayonne, France. ALCOHOL CONSUMPTION AND DUAL DIAGNOSIS IN PENITENTIARY CONTEXT Roberth A. Loor, Programa de Patología Dual Grave del Centro Penitenciario "El Rodeo”, Portoviejo, Ecuador. BRIEF INTERVENTIONS IN ALCOHOLISM; ARE THEY USEFUL IN DUAL PATIENTS? Nelson Feldman, HUG Hôpitaux Universitaires de Genève, Switzerland.
15:00 – 16:30 Symposium – SY45 Room 7 CLOZAPINE FOR SCHIZOPHRENIA AND CO-OCCURRING SUBSTANCE USE: WORTH A SECOND Track: LOOK? Psychopharmacological Chair: Treatments in Dual Alan Green, Department of Psychiatry, Dartmouth Medical School. NH, USA. Disorders Speakers: CLOZAPINE FOR SUBSTANCE USE DISORDERS IN SCHIZOPHRENIA: CURRENT KNOWLEDGE AND A UNIFYING HYPOTHESIS Alan Green, Department of Psychiatry, Dartmouth Medical School. NH, USA. WHAT IS UNUSUAL ABOUT CLOZAPINE? Torgny Svensson, Karolinska Institute. Solna, Sweden. COMPARING THE EFFECT OF CLOZAPINE AND RISPERIDONE ON CANNABIS REWARD IN PATIENTS WITH SCHIZOPHRENIA AND CANNABIS USE DISORDER: A RANDOMIZED FMRI STUDY Marise Machielsen, Academic Psychiatric Center. Amsterdam, The Netherlands. TOWARD A VALID ANIMAL MODEL OF ALCOHOL USE DISORDER IN SCHIZOPHRENIA: CLOZAPINE REDUCES ALCOHOL DRINKING IN THE NEONATAL VENTRAL HIPPOCAMPAL LESIONED RAT Jibran Khokhar, Geisel School of Medicine at Dartmouth. Hanover NH, USA.
www.cipd2015.com Pág. 39
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
15:00 – 16:30 Symposium – SY46 Room 8 TRAUMA CARE FOR THE MOST VULNERABLE Track: Post-Traumatic Chair: Stress Michael Krausz, University of British Columbia. Vancouver, Canada. Speakers: ADDICTION, TRAUMA, MENTAL ILLNESS - TREATMENT OPTIONS FOR COMPLEX CONCURRENT DISORDERS Michael Krausz, University of British Columbia. Vancouver, Canada. GENDER IDENTITY DISORDER & SUD: LET'S GO DEEP INTO THE ABYSS OF TRAUMA Ester di Giacomo, Department of Translational Medicine and Surgery-University of Milano, Italy. TRAUMA EXPERIENCES, AFFECTIVE INESTABILITY, BIPOLAR DISORDER AND ASSOCIATED SUBSTANCE USE: UN-DERLYING MECHANISM AND THERAPEUTIC CONSEQUENCES Christian G. Schütz, University of British Columbia. Vancouver, Canada.
15:00 – 16:30 Medical Educational Room Room 9 Sponsored by the Foundation on Dual Disorders
15:00 – 16:30 Symposium - SY47 Room 10 IDENTIFYING PSYCHIATRIC PATIENTS VULNERABLE TO SUBSTANCE MISUSE Track: Epidemiology Chair: and Dual Disorders Manuel Gurpegui, Universidad de Granada, España. Speakers: AN OVERVIEW OF THE OVERLAP BETWEEN PSYCHIATRIC DISORDERS AND VARIETIES OF SUBSTANCE MISUSE José M. Martínez-Ortega, Instituto de Neurociencias, Universidad de Granada. Granada, España. WHO ARE THE PATIENTS WITH DEPRESSION MORE LIKELY TO ABUSE ALCOHOL? Conor K. Farren, Trinity College Dublin, St Patrick's University Hospital. Dublin, Ireland. HOW DO PATIENTS WITH BIPOLAR DISORDER OR SCHIZOPHRENIA DIFFERENTIALLY REACT TO OPIATES OR STIMULANTS? Icro Maremmani, University of Pisa, University of Siena, Santa Chiara University Hospital, Pisa, Italy. ARE PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER ADDICTED TO TOBACCO A DIFFERENT SUBPOPULATION WITHIN THEIR DIAGNOSTIC GROUP? Manuel Gurpegui, Universidad de Granada, España.
15:00 – 15:45 Workshop - WS12 Room 11 VIOLENCE AND SELF-VIOLENCE IN DUAL DISORDERS Track: Suicide & Dual Chair: Disorders Leo Sher, Mount Sinai School of Medicine/James J. Peters Veterans’ Administration Medical. NY, USA. Speakers: SELF-VIOLENCE IN DUAL DISORDERS Mª Dolores Braquehais, Hospital Universitari Vall d'Hebron. Universitat Autònoma de
www.cipd2015.com Pág. 40
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Barcelona. CIBERSAM. Barcelona, España. NEUROBIOLOGY OF SUICIDAL BEHAVIOR IN ADOLESCENTS WITH DUAL DISORDERS Mª Dolores Picouto, Sant Joan de Déu University Hospital, Universitat de Barcelona. Barcelona, España. HOMICIDAL BEHAVIOR IN DUAL DISORDERS Leo Sher, Mount Sinai School of Medicine/James J. Peters Veterans’ Administration Medical. NY, USA.
15:45 – 16:30 Workshop - WS13 Room 11 GUIDELINES FOR THE PHARMACOLOGICAL AND PSYCHOLOGICAL TREATMENT OF ADULT Track: PATIENTS WITH A PSYCHIATRIC DISORDER AND A COMORBID SUBSTANCE USE Psychopharmacological Chair: Treatments in Dual Miquel Bernardo, Hospital Clínico. Universitat de Barcelona. Barcelona, España. Disorders Speaker: DEVELOPMENT OF THE CLINICAL GUIDELINE OF DUAL PATHOLOGY: GROUP COMPOSITION, MEETINGS, PICO QUESTIONS, ASSESSMENT OF THE SCIENTIFIC EVIDENCE USING THE GRADE SYSTEM, AND RECOMMENDATIONS Luis San, Sant Joan de Deu. Barcelona, España.
15:00 – 16:30 Oral Communications - OC08 Room 12 Chairs: Arkaitz Aguerretxe, Cabinet en Libéral, BIZIA/SETHS, CSAPA BIZIA/Medecins du Monde, France. Elvia Velásquez, Alad (Latinoamerican Association on Addiction). Colombia.
PERSONALITY DISORDER AND ADDICTION S. Božović 1, J.Đorđević 2, S. Čelebić1, D. Pavlović3, M. Prvulović2 1. Special Hospital for Substance Abuse, Belgrade, Serbia. 2. Hospital for Psychiatric Diseases”Dr L Lazarević”, Belgrade, Serbia. 3. Faculty of special education and rehabilitation, Belgrade, Serbia
ADOLESCENT SMOKING AND SYMPTOMS OF DEPRESSION/ANXIETY: EVIDENCE FOR A SELF- MEDICATION HYPOTHESIS N. Carceller-Maicas, A. Martinez-Hernaez Universitat Rovira i Virgili. Tarragona, España.
RESEARCH OF THE COMORBIDITY BETWEEN BORDERLINE PERSONALITY DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND SUBSTANCE USE DISORDER IN AN ADULT PATIENTS SAMPLE C. Maruottolo1,2, A. González1, O. Landeta Rodríguez1,4, J. Balerdi3, M. Fernández3, A. Hernández3 1 AMSA-Teaching and Research Unit, Bilbao, Bizkaia, España. 2 Medicine Faculty, Universidad País Vasco, Bizkaia, España. 3 AMSA Unidad de Día, Bilbao, Bizkaia, España. 4 UNED-Bizkaia, Bizkaia, España.
www.cipd2015.com Pág. 41
Sunday April 19th PRELIMINARY PROGRAM - UPDATED: 10/04/2015
STUDY OF THE EFFECTIVENESS OF A PSYCHODYNAMIC AND SOCIODYNAMIC TREATMENT IN PATIENTS WITH DUAL PATHOLOGY C. Maruottolo Sardella1,2, O. Landeta Rodríguez1,3, C. LLorrens Herrera4 1 AMSA-Teaching and Research Unit, Bilbao, Bizkaia, España. 2 Medicine Faculty, Universidad País Vasco, Bizkaia, España. 3 AMSA Unidad de Día, Bilbao, Bizkaia, España. 4 UNED-Bizkaia, Bizkaia, España.
THE RELATIONSHIP BETWEEN VULNERABLE ATTACHEMENT STYLE, PSYCHOPATHOLOGY, DRUG ABUSE, AND RETENTION IN TREATMENT AMONG METHADONE MAINTENANCE TREATMENT PATIENTS D. Potik1,2, E. Peles1,3, Y. Abramsohn1, M. Adelson1, S. Schreiber1,3 1 Dr. Miriam and Sheldon G. Adelson Clinic for Drug Abuse Treatment and Research, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel. 2 Department of Psychiatry, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel. 3 Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel.
TREATMENT OUTCOMES IN A DUAL DIAGNOSIS THERAPEUTIC COMMUNITY: A FOLLOW-UP STUDY Virginio Salvi, Fabrizio Boccardo, Patrizia Giannini, Metello Corulli Comunità Terapeutica “Il Porto” ONLUS, Moncalieri (TO), Italy.
SELF HARM AMONG WOMAN INJECTING DRUG USERS (IDUS) FROM NORTH EASTERN INDIA Kimneihat Vaiphei St.Johns Medical College and Hospital, India.
16:30 - 17:30 h.
16:30 – 17:15 Plenary Session - PS03 Auditorium A ON THE BLINK: BIPOLAR AND DUAL DISORDERS Track: Bipolar Disorders Chair: Enrique Álvarez, Hospital San Pau de Barcelona, España. Speaker: Eduard Vieta, Hospital Clínic de Barcelona. Universitat de Barcelona. España.
17:15 – 17:30 SESSION AWARD FOR BEST POSTER WINNER Auditorium A
www.cipd2015.com Pág. 42
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
08:30 – 10:00 h.
08:30 – 10:00 Symposium – SY48 Room 2 RESOURCE OPTIMIZATION FOR PATIENTS WITH DRUG ADDICTION DUAL DISORDERS Track: Multidisciplinary Chair: Intervention in Dual Mar Sánchez, Servicio de Psiquiatría del Hospital General Universitario de Ciudad Real. Disorders Castilla la Mancha, España. Speakers: HOSPITAL COORDINATION: ANOTHER WAY OF DUAL PATIENTS TO UCA ACCESS Gloria Cordeiro-Crespo, Servicio de Psiquiatría Mancha Centro de Alcázar de San Juan. Ciudad Real, España. FLOOR SUPPORT THERAPY IN DUAL PATHOLOGY PATIENTS Paloma Sánchez, Unidad de Conductas Adictivas. Ciudad Real, España. IMPROVING ADHERENCE OF DUAL PATIENTS : FROM THE STREET WORKER TO THE UCA Mª Luisa Celorrio, Complejo Hospitalario Universitario de Albacete. Albacete, España.
08:30 – 10:00 Symposium – SY49 Room 3 TOBACCO AND DUAL PATHOLOGY: TOOLS FOR ACTION Track: Tobacco Chair: César A. Sánchez Bello, Hospital Central del Instituto Venezolano de Servicios Sociales Luis Ortega en la Isla de Margarita, Venezuela. Speakers: SMOKING IN PSYCHIATRIC PATIENTS: NEGLECTED EPIDEMIC Débora Serebrisky, Centro de Investigaciones Clínicas WM. Argentina. DUAL ADDICTION: NICOTINE AND COCAINE DEPENDENCE Iván Montoya, Division of Pharmacotherapies and Medical Consequences of Drug Abuse, NIDA, USA. SMOKING AND PATHOLOGICAL GAMBLING César A. Sánchez Bello, Hospital Central del Instituto Venezolano de Servicios Sociales Luis Ortega en la Isla de Margarita, Venezuela. SMOKING AND MENTAL HEALTH PROFESSIONALS IN ARGENTINA Fernando Müller, Proyecto MEDEF, Centro de Investigaciones Clínicas WM, APSA, EGAMA, Unión Antitabáquica Argentina, Argentina.
08:30 – 10:00 New Forum - NF01 Room 4 STATE OF DUAL DISORDER TRAINING, CLINICAL SERVICES AND RESEARCH ACROSS Track: Training in COUNTRIES Dual Diagnosis Chair: Yatan Pal Singh, All India Institute of Medical Sciences (AIIMS) New Delhi, India. Speakers: STATE OF TRAINING, CLINICAL SERVICES AND RESEARCH IN THE FIELD OF DUAL DISORDERS IN FRANCE
www.cipd2015.com Pág. 43
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Amine Benyamina, Centre D'Enseignement, de Recherche Et de Traitement des Addictions. Paris, France. THE STATE OF TRAINING, CLINICAL SERVICES AND RESEARCH IN THE FIELD OF DUAL DISORDERS IN ISRAEL Shaul Lev-Ran, Sheba Medical Center. Tel Hashomer, Israel. THE STATE OF TRAINING, CLINICAL SERVICES AND RESEARCH IN THE FIELD OF DUAL DISORDERS IN SPAIN José Martínez-Raga, Hospital Universitario Doctor Peset y Universitat de Valencia, España. THE STATE OF TRAINING, CLINICAL SERVICES AND RESEARCH IN THE FIELD OF DUAL DISORDERS IN INDIA Yatan Pal Singh, All India Institute of Medical Sciences (AIIMS) New Delhi, India.
08:30 – 10:00 Symposium – SY50 Room 5 AM I AWAKE OR ASLEEP? SLEEP DISORDERS IN DUAL PATHOLOGY Track: Sleep Chair: Disorders and Carmen Barral, Hospital Universitari Vall d'Hebron. Barcelona, España. Dual Diagnosis Speakers: NEUROPHYSIOLOGY OF SLEEP AND ITS DISORDER ADDICTION Fermín Ordoño, Hospital Arnau de Vilanova. Lleida, España. RELATIONS BETWEEN SLEEP AND ADDICTIONS Francesca Cañellas, Hospital Son Dureta. Palma de Mallorca, España. TREATMENT OF SLEEP DISORDERS IN DUAL PATIENTS Lara Grau-López, Hospital Universitari Vall d’Hebron. Barcelona, España.
08:30 – 10:00 Symposium – SY51 Room 6 VIOLENCE IN DUAL DISORDERS: NEURAL CORRELATES AND TREATMENT Track: Penitentiary Chair: (Prisons) and Dual Alessandra Cappai, Maudsley National Health Service Foundation Trust. London, United Disorders Kingdom. Speakers: VIOLENCE AND SUBSTANCE MISUSE Alessandra Cappai, Maudsley National Health Service Foundation Trust. London, United Kingdom. TREATMENT OF VIOLENCE Mrigendra Das, Broadmoor Hospital, West London Mental Health NHS Trust, Oxford School of Psychiatry. London, United Kingdom. VIOLENCE AND NEURAL CORRELATES Carlos Parro, C.S. Mental Retiro. Hospital Universitario Gregorio Marañón. Madrid, España.
08:30 – 10:00 Symposium – SY52 Room 7 ADDICTION: UNCOVERING NEUROBIOLOGICAL COMPLEXITY Track: Multidisciplinary Chair: Intervention in Dual José E. Montejo, Universitat Autònoma de Barcelona. Hospital Universitari Vall d'Hebron. Disorders Barcelona, España. Speakers:
www.cipd2015.com Pág. 44
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
HOW THE ENVIRONMENT INTERACTS WITH GENES IN DRUG ADDICTION Bru Cormand, Universidad de Barcelona. Barcelona, España. NEUROPLASTICITY IN DRUG ADDICTION: INTERACTIVE SYSTEM OF MOLECULAR COMMUNICATION Julio Campos, Neuropsychiatric Research Lab. Universidad Central de Venezuela. Caracas, Venezuela. NEUROBIOLOGICAL COMPLEXITY Ruben Baler, National Institute on Drug Abuse. MD, USA. THERAPEUTICS IN ADDICTION: WHAT IS THE TARGET? José E. Montejo, Universitat Autònoma de Barcelona. Hospital Universitari Vall d'Hebron. Barcelona, España.
08:30 – 10:00 Invited Symposium - IS14 Room 8-9 GAMBLING AND DUAL DISORDERS. WHAT YOU ALWAYS WANT TO KNOW ABOUT Track: Behavioral BEHAVIORAL ADDICTIONS Addictions / Gambling Chair: Disorders Francisco Ferre, Hospital Universitario Gregorio Marañón. Madrid, España. Speakers: EATING DISORDERS AND BEHAVIORAL ADDICTIONS. MEET WITH THE UNEXPERT Francisco Ferre, Hospital Universitario Gregorio Marañón. Madrid, España. EPIDEMIOLOGY GAMBLING DISORDER AND DRUG DEPENDENCE Enrique Echeburua, Facultad de Psicología-Universidad País Vasco, España. GAMBLING DISORDER TREATMENT Susana Jiménez, Hospital Universitario de Bellvitge-IDIBELL. Barcelona, España.
08:30 – 09:15 Workshop - WS14 Room 10 SEXUAL DYSFUNCTION AND SEXUAL HEALTH NEEDS OF PEOPLE WITH DUAL DISORDER: Track: Sexual EVIDENCE AND PRACTICE Dysfunction and Dual Chair: Disorders Elizabeth Hughes, University of York. York, United Kingdom. Speakers: SEXUAL HEALTH NEEDS OF PEOPLE WITH DUAL DISORDERS Elizabeth Hughes, University of York. York, United Kingdom. SEXUAL DYSFUNCTION AS A SIDE -EFFECT OF PSYCHOTROPIC MEDICINES FOR PEOPLE WITH DUAL DISORDERS Ian Hamilton, University of York. York, United Kingdom.
09:15 – 10:00 Workshop - WS15 Room 10 MAKING TREATMENT MORE ACCESSIBLE FOR PEOPLE WITH DUAL DISORDERS Track: Chair/ Speaker: Psychotherapeutic Jim Bott, Roosevelt Hospital, NY, USA. Treatment in Dual Disorders
www.cipd2015.com Pág. 45
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
08:30 – 09:15 Workshop – WS16 Room 11 TREATING DUAL DISORDERS IN YOUNG ADULTS WITH A MULTIDISCIPLINARY NON- Track: Multidisciplinary CONVENTIONAL STRUCTURED APPROACH Intervention in Dual Chair/ Speaker: Disorders Susana E. Méndez, Enterhealth, Residential and Outpatient Services, Dallas TX, USA.
09:15 – 10:00 Workshop – WS17 Room 11 ALCOHOLISM IN ASIA: INCREASE IN PSYCHIATRY COMORBIDITY AND ITS COMORBID Track: Alcohol DISORDERS Chair: Aravind Vaithiyam, Ram Psychiatry Hospital. Madurai, India. Speakers: ALCOHOLISM IN INDIA Aravind Vaithiyam, Ram Psychiatry Hospital. Madurai, India. RELAPSE PREVENTION IN ALCOHOLISM - PHARMACOLOGICAL MANAGEMENT Sujai Subramanian, Aashiana Psychiatric Care Hospital. Delhi, India. OVERLOOKED AND OVERDIAGNOSED COMORBID DEPRESSION IN ALCOHOLISM Takahiko Inagaki, Shiga University of Medical Science. Shiga, Japan.
08:30 – 10:00 Oral Communications - OC09 Room 12 Chairs: Amanda Rodríguez, Vall d'Hebron University Hospital, Barcelona, Spain. Saul Pacurucu, Centro de Recuperación de Adicciones Cuenca, Universidad de Cuenca. Ecuador.
POSTTRAUMATIC STRESS SYMPTOMS AND RELATIONSHIP TO DRUG AND ALCOHOL USE IN AN INTERNATIONAL SAMPLE OF LATIN AMERICAN IMMIGRANTS Lisa R. Fortuna1, Ye Wang1, Michelle Porche2, Zorangeli Ramos1 1 Center for Multicultural Mental Health Services Research, Cambridge Health Alliance, Cambridge, MA, USA. 2 Wellesley Centers for Women, Wellesley College, Wellesley. MA, USA.
THERAPEUTIC ITINERARY IN SITUATIONS OF COMORBIDITY: INTEGRATION AND EQUALITY IN THE HEALTH SYSTEM - BRAZIL A. Assis, M. Silva State University of Rio de Janeiro – RJ, Brasil.
SEX TRADING AMONG MEN AND WOMEN ENTERING TREATMENT FOR DRUG MISUSE IN ENGLAND: ASSOCIATIONS WITH MENTAL WELLBEING G. Gilchrist1, A. Jones2, M. Donmall2, N. Singleton1 1. King’s College London, London, United Kingdom. 2. University of Manchester, Manchester, United Kingdom.
THE IMPACT OF RACIAL DISCRIMINATION ON SUBSTANCE USE IN THE LATIN AMERICAN IMMIGRANT POPULATION
www.cipd2015.com Pág. 46
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Alba-Irene González 1, Adriana Reyes1, Zorangeli Ramos2, Claudia González López3, Francisco Collazos 1 1 Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, CIBERSAM, España. 2 Center for Multicultural Mental Health Research and Harvard Medical School, Boston. MA, USA. 3 Hospital Universitario Fundación Jiménez Díaz, Madrid, España.
EFFECTIVENESS OF THE PERSONAL STRENGTHS INTERVENTION (PSI) ON IMPROVING THE STUDENTS WITH LEARNING DISABILITIES IN IRAN S. Piryaei, M. Khademi Ashkezari Alzahra University, Tehran, Iran.
SUBSTANCE USE AND THE PROTECTIVE EFFECT OF MATERNAL WARMTH O. Santesteban1,2, M. Ramos-Olazagasti1, R. E. Eisenberg1, H. R. Bird1, G. Canino3, C. S. Duarte1 1 Columbia University Medical Center - N.Y. Psychiatric Institute, New York, NY, USA. 2 Universitat Rovira i Virgili, Reus, Tarragona, España. 3 Behavioral Sciences Research Institute, University of Puerto Rico, San Juan, Puerto Rico.
THE STUDY OF AGGRESSION LEVEL IN PATIENTS WITH COMPUTER ADDICTION AND COMORBID PSYCHIATRIC DISORDERS D.C. Mavani1, A.V. Dyachenko1, V.A. Soldatkin2, O.A. Bukhanovskaya1 1 Scientific Center for Treatment and Rehabilitation "Phoenix", Rostov-On-Don, Russia. 2 Rostov State Medical University, Rostov-On-Don, Russia.
DUAL DIAGNOSIS IN PRIVATE PRACTICE IN MOROCCO M. Paes Mohamed V University in Rabat, Morocco.
10:00 – 11:30 h.
10:00 – 11:30 Symposium – SY53 Room 2 PATTERNS OF CANNABIS USE THROUGH THE LIFESPAN IN DUALLY AND NON-DUALLY Track: Cannabis and DIAGNOSED PATIENTS Dual Disorders Chair: Nieves Martínez-Luna, Hospital Universitari Vall d’Hebron. Barcelona, España. Speakers: PATTERNS OF CANNABIS USE, AND THE PRESENCE OF DUAL DIAGNOSIS IN CHILDREN AND TEENAGERS Javier Goti, Hospital Clinic. Barcelona, España. PATTERNS OF CANNABIS USE IN ADULTS -18 TO 55 YEARS- AND THE PRESENCE OF DUAL DIAGNOSIS Giovanni Martinotti, University "G.D'Annunzio", Chieti, Italy. PATTERNS OF CANNABIS USE IN ADULTS -56 YEARS AND IN OLDER LIFE- AND THE
www.cipd2015.com Pág. 47
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
PRESENCE OF DUAL DIAGNOSIS Begoña Gonzalvo, Centre d'Atenció I Seguiment Sant Boi Llobregat. Benito Menni CASM. Barcelona, España.
10:00 – 11:30 Invited Symposium - IS15 Room 3 THE INTERCOURSE OF SEXUAL ADDICTION AND DUAL DISORDERS Track: Sexual Chair: Dysfunction Josep Mª Farré, Hospital Universitario Quirón-Dexeus. Barcelona, España. Speakers: NEW TRENDS IN SEXUALITY AND DRUGS José Antonio Navarro, Hospital Universitario Vall d’Hebron de Barcelona/Clínica Galatea. Barcelona, España. SEXUAL LIFE AFTER PSYCHOTROPIC DRUGS Ángel Luis Montejo, Universidad de Salamanca, Salamanca, España.
10:00 – 11:30 Symposium – SY54 Room 4 MEDICAL COMORBIDITY IN DUAL PATHOLOGY Track: Evaluation Chair: processes in Dual Maite San Emeterio, Centre d´Higiene Mental Les Corts. Barcelona, España. Disorders Speakers: SOMATIC ATTENTION AND PROTOCOL TO DUAL PATIENT Maite San Emeterio, Centre d´Higiene Mental Les Corts. Barcelona, España. HIV IN DUAL PATIENT José Mª Vazquez, Centre d'Atenció i Seguiment de Sants. Barcelona, España. NEUROLOGICAL COMORBIDITY IN YOUNG DUAL PATIENT Carolina Franco, Centre d´Higiene Mental Les Corts. Barcelona, España.
10:00 – 10:45 Book Presentation - BP01 Room 5 NEW PSYCHOACTIVE DRUGS Chair/ Speaker: Helen Dolengevich Segal, Hospital Universitario del Henares. Madrid, España.
10:45 – 11:30 Workshop – WS18 Room 5 DUAL DISORDERS IN MENTAL HEALTH PATIENTS Track: Evaluation Chair: processes in Dual Marcela Waisman, Fundación para la Lucha contra las Enfermedades Neurológicas de la Disorders Infancia (FLENI). Buenos Aires, Argentina. Speakers: SCHIZOAFFECTIVE DISORDER AND ADDICTIONS Marcela Waisman, Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI). Buenos Aires, Argentina. SMOKING AND ADDICTIONS Debora Serebrisky, Centro de Investigaciones Clínicas WM, Argentina. AUTISM SPECTRUM DISORDER AND ADDICTIONS Bettina Ortiz, Cátedra de Psiquiatría del Hospital de Clínicas, Asunción, Paraguay.
www.cipd2015.com Pág. 48
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
10:00 – 11:30 Symposium - SY55 Room 6 DUAL DISORDERS IN SUBSTANCE USERS IN THE CRIMINAL JUSTICE SYSTEM - CLINICAL Track: Penitentiary COURSE AND THE EFFECT OF TREATMENT (Prisons) and Dual Chair: Disorders Anders Hakansson, Lund University. Lund, Sweden. Speakers: OPIATE USE AS A RISK FACTOR FOR CRIMINAL RECIDIVISM, IN-PATIENT TREATMENT AND DEATH IN CRIMINAL JUSTICE CLIENTS - POTENTIAL FOR INTERVENTION Anders Hakansson, Lund University. Lund, Sweden. SUBSTANCE USE DISORDERS AND CO-MORBIDITY WITH PSYCHIATRIC DISEASE IN THE CRIMINAL JUSTICE SETTING - POTENTIAL FOR INTERVENTION Johan Franck, Karolinska Institute. Solna, Sweden. RISK FACTORS FOR OVERDOSES, SUICIDES AND SELF-INFLICTED DEATH WITH UNDETERMINED INTENT IN CRIMINALS WITH SUBSTANCE USE PROBLEMS Martin Olsson, Lund University. Lund, Sweden. LONG TERM RISK OF SUBSTANCE-INDUCED AND PRIMARY PSYCHOSIS AFTER RELEASE FROM PRISON. A LONGITUDINAL STUDY OF SUBSTANCE USERS Eline Borger-Rognli, Oslo University. Oslo, Norway.
10:00 – 11:30 Symposium – SY56 Room 7 DEVELOPING THE CAPABILITIES OF THE MENTAL HEALTH AND SUBSTANCE USE Track: Multidisciplinary TREATMENT WORKFORCE FOR DUAL DISORDERS: EXAMPLES FROM RESEARCH AND Intervention in Dual PRACTICE Disorders Chair: Elizabeth Hughes, University of York. York, United Kingdom. Speakers: ESTABLISHING AND MAINTAINING A LOCAL DUAL DIAGNOSIS NETWORK Elizabeth Hughes, University of York. York, United Kingdom. LEARNING FROM SUBSTANCE USE INCIDENTS Cheryl Kipping, Maudsley National Health Service Foundation Trust. London, United Kingdom. MENTAL HEALTH WORKERS EXPERIENCE OF USING MOTIVATIONAL INTERVIEWING FOR DUAL DISORDERS Justine Trippier, National Health Service Foundation Trust. London, United Kingdom. ESTABLISHING AND MAINTAINING A LOCAL DUAL DIAGNOSIS NETWORK Ian Hamilton, University of York. York, United Kingdom.
10:00 – 10:45 Main Lecture – ML12 Room 8-9 SUBSTANCE USE AND SCHIZOPHRENIA: RISK AND REWARD Track: Psychosis Chair: Jerónimo Sáiz, Universidad de Alcalá de Henares, Madrid, España. Speaker: Alan Green, Department of Psychiatry, Dartmouth Medical School, Lebanon. MD, USA.
10:45 – 11:30 Main Lecture – ML13 Room 8-9 PERSONALIZED TREATMENT OF ALCOHOL USE DISORDER WITH TOPIRAMATE Track: Alcohol Chair: Juan Gibert, Universidad de Cádiz, España. Speaker: Henry R. Kranzler, Perelman School of Medicine, University of Pennsylvania. Treatment Research Center. PA, USA.
www.cipd2015.com Pág. 49
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
10:00 – 10:45 Workshop – WS19 Room 10 PSYCHOLOGICAL PROBLEMS AMONG CHILDREN WHO ARE SEXUALLY ABUSED Track: Personality Chair/ Speaker: Disorders Md.Masbah Uddin Ahmed, Bandhu Social Welfare Society. Dhaka, Bangladesh.
10:45 – 11:30 Workshop – WS20 Room 10 TRENDS OF TISSUE SELECTION IN EPIGENETIC INVESTIGATIONS IN MAJOR PSYCHOSES: Track: Psychosis NECESSITY FOR A UNIFIED FRAMEWORK IN PSYCHIATRIC EPIGENETIC STUDIES? Bahar Massih, Tarbiat Modares University, Bahar Medical Laboratory. Tehran, Iran.
10:00 – 10:45 Workshop – WS21 Room 11 PSYCHOPHARMACOLOGICAL TREATMENT IN DUAL DISORDERS: THE CASE OF Track: SCHIZOPHRENIA AND SUBSTANCE ABUSE Psychopharmacological Chair: Treatments in Dual Luis A. Núñez, Centro Médico de Diagnóstico. Pamplona, Navarra, España. Disorders Speakers: PALIPERIDONE PALMITATE IN DUAL DIAGNOSIS. A RETROSPECTIVE STUDY Luis A. Núñez, Centro Médico de Diagnóstico de Pamplona. Navarra, España. CURRENT TENDENCIES IN PSYCHOPHARMACOLOGICAL TREATMENT IN DUAL PATHOLOGY María Gracia, Centro Salud Mental de Tudela. Navarra, España. SCHIZOPHRENIA AND COMORBID SUBSTANCE ABUSE. AN UPDATE Olga Arbeo, Centro de Día Zuría, Pamplona. Navarra, España.
10:45 – 11:30 Workshop - WS22 Room 11 DUAL DISORDERS: NEW PROBLEMS, NEW SOLUTIONS Track: Multidisciplinary Chair: Intervention in Dual Juan J. Hernández, Cruz Roja Española. Madrid, España. Disorders Speakers: MULTI-CHANNEL INFORMATION AND DRUG PREVENTION SERVICE OF SPANISH RED CROSS Cristina Ferrero, Cruz Roja Española. Madrid, España. PREVENTION SERVICE AND TREATMENT OF ADDICTION TO TECHNOLOGY Silvia Allué, Asociación Punto Omega, Móstoles. Madrid, España. POST-DISCHARGE MONITORING PROGRAM OF THE SPANISH RED CROSS Juan J. Hernández, Cruz Roja Española. Madrid, España.
10:00 – 11:30 Oral Communications - OC10 Room 12 Chairs: Constanza Daigre, Servicio de Psiquiatría Hospital Universitario Vall d’Hebron, Barcelona, España. Florence Vorspan, Publique-Hôpitaux de Paris, France.
POST HOC ANALYSES OF THE EFFICACY OF LISDEXAMFETAMINE DIMESYLATE IN ADULTS PREVIOUSLY TREATED WITH ATTENTION DEFICIT/HYPERACTIVITY DISORDER MEDICATION L.A. Adler,1 J. Wu,2 M. Madhoo,2 B. Caballero3 1 New York University School of Medicine, New York, NY, USA. 2 Shire, Wayne, PA, USA. 3 Shire, Zug, Switzerland.
INTEGRATIVE PROGRAM MODEL [IPM]: DIALECTICAL BEHAVIOR AND
www.cipd2015.com Pág. 50
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
PSYCHODYNAMICALLY INFORMED GROUP PSYCHOTHERAPY Claudia Arlo Addiction Institute of NY, Mt Sinai Roosevelt Hosp./Fordham University. NY, USA.
ANXIETY IN ADDICTIONS Antonio Domingo Pisano Hospital J.T. Borda, Buenos Aires, Argentina.
ANXIETY DISORDERS ARE ASSOCIATED WITH EARLY ONSET OF HEROIN USE AND RAPID TRANSITION TO DEPENDENCE IN METHADONE MAINTAINED PATIENTS Emily Karsinti1, Vanessa Bloch1, Jan Scott2, Jean Pierre Lépine1, Frank Bellivier1, Florence Vorspan1 1 APHP - Hôpital Fernand Widal, Paris, France. 2 Institute of Neuroscience, Newcastle University; Centre for Affective Disorders, Institute of Psychiatry, London, United Kingdom.
ASSESSMENT OF DEPRESSION AND ANXIETY IN PATIENTS WITH TREATED AND UNTREATED RESISTANT HYPERTENSION: A PILOT STUDY A.Mermerelis1, A. Douzenis2, S-M Kyvelou1, Vellinga A1, C. Stefanadis3, C. Papageorgiou4 1 Galway University Hospital , Ireland. 2 2nd psychiatry clinic Athens University, Greece. 3 1st cardiology clinic Athens University, Greece. 4 1st psychiatry clinic Athens University, Greece.
PERSONALITY CHARACTERS AND TENDENCY TO ADDICTION: A COMPARATIVE STUDY BETWEEN ADDICTED AND NONADDICTED PEOPLE Gholamali Nikpour1, Alireza Homayouni 2, Arsalan Khanmohammadi Otaghsara3, Seyed Jalal Mosavi Amiri 4 1 Allameh Tabatabaii University, Tehran, Iran. 2 College of psychology, Bandargaz Branch, Islamic Azad University, Bandargaz, Iran. 3 College of psychology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran. 4 Medical Clinic of Dr. Mosavi, Amirkola, Iran.
ANXIETY AND ALCOHOL CONSUMPTION Delia Marina Podea1,2, Karol-Julien Wild1, Ionela Natalia Cotos1,2 1 “Vasile Goldis” Western University of Arad -Psychiatry Department, Romania. 2 County Clinical Emergency Hospital of Arad- Psychiatry Department, Romania.
BORDERLINE PERSONALITY DISORDER AND SUBSTANCE USE DISORDER: ARE THEY A REAL COUPLE? T. Sousa-Ferreira 1, M. Ferreira 2, S. Ferreira1, J. Amaral1, T.Cabral 1 1. Department of Psychiatry And Mental Health - Centro Hospitalar Tâmega e Sousa, Penafiel, Portugal. 2. Department of Psychiatry And Mental Health – Hospital de Braga, Braga, Portugal.
www.cipd2015.com Pág. 51
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
PROFESSIONALS WORKING WITH PATIENTS WITH ATTACHMENT DISORDER AND DUAL DIAGNOSIS- HOW TO NAVIGATE IN PROJECTIVE IDENTIFICATIONS C. Madsen, A.L.Kronborg Municipality of Skanderborg, Skanderborg, Denmark.
11:30 – 13:00 h.
11:30 – 12:15 Main Lecture - ML14 Room 2 DEPRESSION AND DUAL DISORDERS Track: Depression Chair: J. Manuel Menchón, Hospital Universitari de Bellvitge. Barcelona, España. Speaker: Marta Torrens, Institut de Neuropsiquiatria I Addiccions-Parc de Salut Mar, Universitat Autònom, Barcelona, España.
12:15 – 13:00 Main Lecture - ML15 Room 2 SUICIDE Track: Suicide & Dual Chair: Disorders Lucas Giner, Universidad de Sevilla. Sevilla, España. Speaker: Leo Sher, Mount Sinai School of Medicine/James J. Peters Veterans’ Administration Medical. NY, USA.
11:30 – 13:00 Symposium – SY57 Room 3 DUAL PATHOLOGY TREATMENT IN DRUG ADDICTION CENTERS Track: Chair: Psychopharmacological Rocío Molina, Centro de Atención a las Drogodependencias de Arganzuela. Madrid, España. Treatments in Dual Speakers: Disorders ANXIETY-DEPRESSION DISORDERS IN ALCOHOLIC PATIENTS. A PERSPECTIVE FROM A CAD (DRUG ADDICTION TREATMENT CENTER) Pilar San Juan, Centro de Atención a Las Drogodependencias de Villaverde. Madrid, España. USE OF ATYPICAL ANTIPSYCHOTICS IN DUAL DIAGNOSIS Dolores Baño, Centro de Atención a Drogodependencias de Majadahonda. Madrid, España. OPIOID SYSTEM IN PATIENTS WITH BORDERLINE PERSONALITY DISORDER THAT ARE GOING TO DRUG ADDICTS CARE CENTER FOR ALCOHOL AND OPIOID DEPENDENCE Rocío Molina, Centro de Atención a Las Drogodependencias de Arganzuela. Madrid, España.
11:30 – 13:00 Invited Symposium – IS16 Room 4 INTEGRATED RESOURCES IN DUAL DISORDERS Track: Planning, Chair: regulations and Luis Alfonzo B., Organización Panamericana de la salud, Washington, DC, USA. resource management Speakers: ADMISSION UNITS IN DUAL PATHOLOGY Célia Franco, Unidade de Patologia Dual, Centro Hospitalar Universitário de Coimbra, Portugal. RESOURCES IN DUAL PATHOLOGY
www.cipd2015.com Pág. 52
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Carlos Roncero, Universidad Autónoma de Barcelona, España. RESOURCES FOR DUAL PSYCHOTICS Chus Ezcurra, Hospital Psiquiátrico de Álava, Vitoria, España.
11:30 – 12:15 Workshop - WS23 Room 5 CONCISE EMOTIONAL INTEGRAL TREATMENT PROGRAM IN DUAL DISORDERS: A PILOT Track: Basic research STUDY in Dual Disorders Chair: Araceli García, Investigación Psicológia en UNED. Madrid, España. Speakers: Araceli García, Investigación Psicológia en UNED. Madrid, España. Vicent Plá, Proyecto Hombre de Gandía. Comunidad Valenciana, España.
12:15 – 13:00 Workshop - WS24 Room 5 UPDATING THE APPROACH TO DUAL PATIENTS AT THE GENERAL HOSPITAL Track: Multidisciplinary Chair: Intervention in Dual Francisco J. Quintero, Hospital Universitario Infanta Leonor. Madrid, España. Disorders Speakers: SOMATIC COMORBIDITY IN DUAL PATIENT Fernando Mora, Hospital Infanta Leonor. Universidad de Alcalá. Madrid, España. ADDRESSING THE TURMOIL IN THE DUAL PATIENT Javier Correas, Hospital Universitario del Henares. Madrid, España. HCV AS A MARKER OF SEVERITY IN PATIENTS WITH DUAL DIAGNOSIS Helen Dolengevich, Hospital Universitario del Henares. Madrid, España.
11:30 – 13:00 New Forum - NF02 Room 6 THE COLORFUL SPECTRUM OF DUAL DISORDERS Track: Psychosis Chair: Arnt Schellekens, Radboud University, Nijmegen Institute for Scientist Practitioners in Addiction. Nijmegen, The Netherlands. Speakers: ALTERED REWARD PROCESSING DEFICITS IN ADHD AND CO-OCCURRING SUBSTANCE USE DISORDERS Arnt Schellekens, Radboud University, Nijmegen Institute for Scientist Practitioners In Addiction. Nijmegen, The Netherlands. DEMORALIZATION IN DUALLY DIAGNOSED PATIENTS Gerdien de Weert, Radboud University, Nijmegen Institute for Scientist Practitioners In Addiction. Nijmegen, The Netherlands. PSYCHOTRAUMA AND ADDICTION Tim Kok, Tactus Addiction Treatment. Enschede, The Netherlands. ACUTE AND CHRONIC EFFECTS OF CANNABINOIDS ON BRAIN: PATHWAYS TO PSYCHOSIS Albert Batalla, Tactus Addiction Treatment. Deventer, The Netherlands. DUAL DIAGNOSES IN A SAMPLE OF SEVERELY CRIMINAL FEMALE OFFENDERS Eric Blaauw, Verslavingszorg Noord Nederland (VNN). Groningen, The Netherlands. PSYCHOPATHOLOGY AMONG GHB USERS
www.cipd2015.com Pág. 53
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Rama Kamal, Novadic-Kentron Addiction Care Netwerk. Vught, The Netherlands.
11:30 – 13:00 Symposium – SY58 Room 7 HOW TO TREAT DUAL PATIENTS: EXPERIENCE OF DUAL PATHOLOGY UNITS Track: Multidisciplinary Chair: Intervention in Dual António G. da Silva, Associaçâo Brasileira de Psiquiatria. Rio de Janeiro, Brasil. Disorders Speakers: EVALUATION OF TREATMENT IN A DUAL PATHOLOGY UNIT, ADDICTION INSTITUTE OF MADRID SALUD Diego Urgelés, Clínica Nuestra Señora de La Paz. Madrid, España. TREATMENT PHASES IN DUAL PATIENTS Vera Martins, Unidade Patologia Dual. C.H.U. Coimbra, Portugal. PHARMACOLOGICAL INTERVENTIONS IN DUAL PATIENTS Tânia Silva, Centro Hospitalar Universitario de Coimbra, Portugal. MULTIDISCIPLINARY TEAM IN DUAL PATIENT'S TREATMENT Cândida Henriques, Centro Hospitalar Universitário de Coimbra, Portugal.
11:30 – 13:00 Symposium – SY59 Room 8-9 PATHOLOGICAL GAMBLING, INTERNET ADDICTION AND THE INTRIGUING FLASHBACK: Track: Behavioral DECIPHERING THE CHALLENGING PUZZLE addictions / Gambling Chair: Disorders Arturo G. Lerner, Lev- Hasharon MHC, Sackler School of Medicine Tel Aviv University. Tel Aviv, Israel. Speakers: GENDER DIFFERENCES AND DUAL DIAGNOSIS IN PATHOLOGICAL GAMBLERS Pinhas Dannon, Beer Yaakov-Ness Ziona MHC, Sackler School of Medicine Tel Aviv University. Tel Aviv, Israel. FLASHBACKS (FB) AND HALLUCINOGEN PERSISTING PERCEPTION DISORDER (HPPD): CLINICAL TOPICS AND TREATMENT APPROACH Arturo G. Lerner, Lev- Hasharon MHC, Sackler School of Medicine Tel Aviv University. Tel Aviv, Israel. COMORBIDITY OF INTERNET ADDICTION WITH OTHER PSYCHIATRIC CONDITIONS Aviv Weinstein, University of Ariel. Ariel, Israel.
11:30 – 12:15 Workshop - WS25 Room 10 SUBSTANCE USE & INTELLECTUAL DISABILITY Track: Multidisciplinary Chair: Intervention in Dual Joanne E.L. Van Der Nagel, Tactus Addiction Treatment. Deventer, The Netherlands. Disorders Speakers: SUBSTANCE USE AMONG PERSONS WITH ID; DIAGNOSIS AND ASSESSMENT, CASE COORDINATION AND OUTPATIENT SERVICES Joanne Van Der Nagel, Tactus Addiction Treatment. Deventer, The Netherlands. SUBSTANCE USE AMONG PERSONS WITH ID; AN INPATIENT TREATMENT PROGRAM
www.cipd2015.com Pág. 54
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Fleur Vruwink, Tactus Addiction Care. Deventer, The Netherlands.
12:15 – 13:00 Workshop – WS26 Room 10 UPDATE ON PATHOLOGICAL GAMBLING AND DUAL PATHOLOGY MANAGEMENT Track: Behavioral Chair: addictions / Gambling César A. Sánchez Bello, Hospital Central del Instituto Venezolano de Servicios Sociales Luis Disorders Ortega en la Isla de Margarita, Venezuela. Speakers: César A. Sánchez-Bello, Hospital Central del Instituto Venezolano de Servicios Sociales Luis Ortega en la Isla de Margarita, Venezuela. Irene Chitty, Instituto Venezolano de Servicios Sociales Luis Ortega en la Isla de Margarita, Venezuela.
11:30 – 13:00 Symposium – SY60 Room 11 PERSONALITY AND ADDICTION: NEW ADVANCES, NEW CONTROVERSIES Track: Personality Chair: Disorders Lola Peris, Centre Neuchâtelois de Psychiatrie (CNP), Neuchâtel, Switzerland. Speakers: PERSONALITY, PERSONALITY DISORDERS AND ADDICTION: THE ISSUES OF THEIR NEUROBIOLOGICAL LINK Lola Peris, Centre Neuchâtelois de Psychiatrie (CNP), Neuchâtel, Switzerland. MUST WE WAIT TO DIAGNOSE DUAL PERSONALITY DISORDERS? Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España. USE OF SUBSTANCES AND SUICIDE: THE ROLE OF PERSONALITY TRAITS Víctor Pérez-Sola, CIBERSAM / Hospital del Mar, Barcelona, España.
11:30 – 13:00 Oral Communications - OC11 Room 12 Chairs: Mar Ramos, Hospital Universitari Vall d'Hebron. Barcelona, España. Yenny Saad, Faculta de Medicina de la Universidad de la República del Uruguay, Uruguay.
POLY-DRUG USE AND MENTAL DISTRESS COMORBIDITY: A 10-YEAR PROSPECTIVE STUDY OF PATIENTS FROM SUBSTANCE ABUSE TREATMENT IN NORWAY J. Burdzovic Andreas, G. Lauritzen, T. Nordfjærn Norwegian Institute for Alcohol and Drug Research (SIRUS), Oslo, Norway.
TOBACCO USE AND BIPOLAR DISORDER. THE BRIEF INTERVENTION AT COMMUNITY MENTAL HEALTH V. Millán Aguilar Rodríguez, C. García Caro, M. Ayora Rodrírguez, E. Rodríguez Jimenez, A. Ruiz Arcos, A. Padilla Mata, M. Ordovás Gonzalez, L. Asensio Aguerri, E. Prieto Bonilla, F. Sarramea Crespo Hospital Universitario Reina Sofía, Córdoba, España.
www.cipd2015.com Pág. 55
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
BIPOLAR DISORDER AND SUBSTANCE USE DISORDER COMORBIDITY: CYCLOTHYMIC ENDOPHENOTYPE S. Kesebir1, O. Noyan1, S. Nurmedov 1, A.E. Darcin2 1 Uskudar University, Istanbul, Turkey. 2 Kanuni State Hospital, Istanbul, Turkey.
DISPARITIES IN ACCESS AND EFFECTIVENESS FOR EVIDENCE-BASED SUPPORTED EMPLOYMENT FOR PERSONS WITH CO-OCCURRING SERIOUS MENTAL ILLNESS (SMI) AND SUBSTANCE USE DISORDER (SUD): EVIDENCE FROM A STATE-WIDE POLICY INTERVENTION David Salkever1, Brent Gibbons2, Michael Abrams3, Kevin Baier2 1The School of Public Policy at the University of Maryland-Baltimore County (UMBC); Johns Hopkins-Bloomberg School of Public Health, Johns Hopkins University. MA, USA. 2 Maryland Institute for Policy Analysis and Research and the School of Public Policy, UMBC. MA, USA. 3 Hilltop Institute and the School of Public Policy, UMBC. MA, USA.
EFFECT OF TOBACCO ABSTINENCE AND BUPROPION AUGMENTATION ON COGNITIVE FUNCTION IN SCHIZOPHRENIC PATIENTS: A DOUBLE-BLIND PLACEBO AND CONTROLLED STUDY Najmeh Shahini 1,2, Mansoreh Mirzadeh 1.2, Mohammad Reza Fayyazi Bordbar1.2 1 Psychiatry and Behavioural Sciences Research Center, Ibn-e-Sina Hospital, Faculty of Medicine. Mashhad, Iran. 2 Mashhad University of Medical Sciences, Mashhad, Iran.
PSYCHOSIS AFTER OPIOD WITHDRAWAL – ARE OPIOID DRUGS ANTYPSYCHOTICS? V. Vila Nova 1, C. Oliveira 2, C. Cotta1 1 Centro Hospitalar Barreiro-Montijo, Barreiro, Portugal. 2 Centro Hospitalar Psiquiátrico de Lisboa, Lisboa, Portugal.
NEUROBEHAVIORAL ASPECTS OF OMEGA-3 FATTY ACIDS: POSSIBLE MECHANISM AND THERAPEUTIC VALUE IN DUAL DIAGNOSIS S. Rabinovitz University of Haifa, Haifa, Israel.
NEUROCOGNITIVE CHARACTERISTICS OF PSYCHOTIC SYMPTOMS IN YOUNG ADULTS WITH HIGH FUNCTIONING AUTISM R. Rinaldi 1,2, E. Jacquet 3, L. Lefebvre 1,2 1 Neuropsychology and Cognitive Sciences Department, University of Mons, Belgium. 2 UMONS Research Institute for Health Sciences and Technology, University of Mons, Belgium. 3 Faculty of Psychology and Educational Sciences, University of Mons, Belgium.
POLITICS AND ECONOMICS OF METHADONE IN RURAL CANADA Sanjay Siddhartha1, Ajay Wagle2 1 Miramichi Hospital, Miramichi, Canada.
www.cipd2015.com Pág. 56
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
2 Norwich NHS Trust, Canada. 13:00 – 14:30 h.
13:00 – 14:30 Symposium – SY61 Room 2 PARKINSON'S DISEASE, HEADACHE AND CHRONIC FATIGUE SYNDROME: EXPLANATORY Track: MODELS OF NEUROBIOLOGICAL MECHANISMS OF SUBSTANCE USE DISORDERS Psychopharmacological Chair: Treatments in Dual Luis Sánchez Planell, Universidad Autónoma de Barcelona, España. Disorders Speakers: DISORDERS OF IMPULSE CONTROL AND DOPAMINE DYSREGULATION SYNDROME IN PARKINSON'S DISEASE Naia Sáez-Francàs, Hospital Vall d'Hebron. Barcelona, España. IS PERSONALITY A FACTOR INVOLVED IN THE APPEARANCE OF CHRONIC FATIGUE SYNDROME AND ITS RELATION TO SUBSTANCE USE DISORDERS? Natalia Calvo, Universitat Autònoma de Barcelona, Hospital Vall d'Hebron. Barcelona, España. HEADACHE AND MISUSE OF MEDICATION Patricia Pozo, Servicio de Neurología, Hospital Vall d´Hebron, Barcelona, España.
13:00 – 14:30 Symposium - SY62 Room 3 RESULTS FROM THE CO-OCCURRING DISORDERS MULTICENTER STUDY IN MEXICAN Track: Epidemiology RESIDENTIAL CENTERS and Dual Disorders Chair: Rodrigo Marin-Navarrete, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. Ciudad de México, México. Speakers: CO-OCCURRING DISORDERS IN RESIDENTIAL CENTERS A PUBLIC HEALTH CONCERN IN MEXICO Rodrigo Marin-Navarrete, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. Ciudad de México, México. LATENT CLASS PROFILE OF SEXUAL RISK BEHAVIOR AND CO-OCCURRING DISORDERS IN A SAMPLE OF RESIDENTIAL PATIENTS Luis Villalobos-Gallegos, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Universidad Autonómica Nacional. Ciudad de México, México. PREVALENCE AND CORRELATES OF CO-OCCURRING DISORDERS IN A FEMALE SUB-SAMPLE: A SECONDARY ANALYSIS Ana de la Fuente, Universidad La Salle. Ciudad de México, México.
13:00 – 14:30 Invited Symposium - IS17 Room 4 DUAL DISORDERS: NEW PHARMACOLOGICAL TREATMENTS Track: Chair: Psychopharmacological Diego Palau, Corporació Sanitaria i Unviersitari Parc Taulí, Sabadell. Barcelona, España. Treatments in Dual Speaker: Disorders VARENICLINE IN SMOKING CESSATION THROUGH SMOKING REDUCTION
www.cipd2015.com Pág. 57
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Eugeni Bruguera, Hospital Universitari Vall d'Hebron. Barcelona, España. PHARMACOLOGICAL ADVANCES IN THE MODULATION OF NICOTINIC CHOLINERGIC SYSTEMS: THERAPEUTIC IMPLICATIONS IN DUAL PATHOLOGY Cecilio Álamo, Universidad de Alcalá, Hospital de la Paz, España. ADDRESSING TOBACCO CESSATION IN AN INPATIENT ADDICTION UNIT Mª Cristina Pinet, Hospital de la Santa Creu i Sant Pau. Barcelona, España.
13:00 – 14:30 Symposium - SY63 Room 5 DIFFERENTIAL ASPECTS IN ADULTS WITH ‘ADHD’ IN DIFFERENT SUBSTANCE USE Track: Attention Deficit DISORDERS Chair: José R. Gutiérrez, Hospital Perpetuo Socorro. Badajoz, España. Speakers: TRANSLATIONAL ASPECTS AND CLINICAL UTILITY OF MANAGEMENT OF ADHD IN ADULTS WITH SUD BY DIFFERENT TYPES OF SUBSTANCES José R. Gutiérrez, Hospital Perpetuo Socorro. Badajoz, España. GENERAL AND SPECIFIC FREQUENCY OF ADHD IN A SAMPLE OF ADULT PATIENTS WITH SUD BY DIFFERENT TYPES OF SUBSTANCES: ANALYSIS OF THE SAMPLE. José M. Zoido, Centro Extremeño de Atención a la Drogodependencia. CEDEX. Badajoz, España. INFLUENCES OF AFFECTIVE VARIABLES IN THE ASSESSMENT OF ADHD IN A SAMPLE OF ADULTS WITH SUD BY DIFFERENT TYPES OF SUBSTANCES Francisco J.R.Pino, Unidad de Salud Mental de Montijo. Badajoz, España.
13:00 – 14:30 Symposium – SY64 Room 6 THREE REALITIES IN A SINGLE PATIENT IN HEALTHCARE SERVICES FOR DRUG ADDICTION Track: Legal aspects in AND DUAL PATHOLOGY Dual Disorders Chair: Isabel Aguilar, Santa Cruz de Tenerife, España. Speakers: THE NEED FOR A STRATEGY AND COORDINATION HEALTH PLAN FOR DUAL PATHOLOGY AT THE MURCIAN HEALTH SERVICE Desiderio Mejías, Hospital de la Vega Lorenzo Guirao, Cieza. Murcia, España. APPROACH TO DUAL DIAGNOSIS IN ANDALUSIA: "A CLINICAL ENTITY, TWO HEALTHCARE NETWORKS Juan Ramírez, Servicio Provincial Drogodependencias y Adicciones Huelva, España. DEPENDENCE OF DRUG ADDICTIONS ON SUBSIDY POLICIES IN THE CANARIES. REGULATIONS AND ISSUES Isabel Aguilar, Santa Cruz de Tenerife, España.
13:00 – 14:30 Symposium - SY65 Room 8-9 DUAL DISORDERS IN A TRANSSEXUALITY AND GENDER IDENTITY UNIT FROM THE PUBLIC Track: Gender and Dual HEALTH SERVICE. RESEARCH, MANAGEMENT AND INTERVENTION Diagnosis Chair:
www.cipd2015.com Pág. 58
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
Pedro M. P. Matos, Hospital Regional Universitario de Málaga. Málaga, España. Speakers: RESEARCH ABOUT SUBSTANCE CONSUMPTION AND MENTAL HEALTH FROM THE MINORITY STRESS MODEL PERSPECTIVE José Gúzman, Hospital Regional Universitario de Málaga. Instituto de Investigación Biomédica. Málaga, España. VICTIMIZATION AND VIOLENCE AND ITS RELATION WITH SUBSTANCE USE IN TRANSSEXUALS Pedro M. Paulino Matos, Hospital Regional Universitario de Málaga. Málaga, España. SUBSTANCE USE AND SUICIDAL BEHAVIORS IN TRANSSEXUALS' INDIVIDUALS Lucía Pérez, Hospital Regional Universitario de Málaga. Universidad de Málaga. Málaga, España.
13:00 – 14:30 Oral Communications - OC12 Room 12 Chairs: Josep Salavert, Hospital San Rafael, Barcelona, España. Mariano Montenegro, Universidad de Chile, Santiago, Chile.
AGE RELATED EFFECTS ON COGNITIVE FUNCTIONING IN PATIENTS WITH SCHIZOPHRENIA AND COCAINE DEPENDENCE I.Benaiges1, J.M. Serra-Grabulosa1,2, A. Adan1,3 1 Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, España. 2 August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, España. 3 Institute for Brain, Cognition and Behavior (IR3C), Barcelona, España.
CLINICAL FEATURES OF SCHIZOPHRENIA IN PERSONS USING NARCOTIC SUBSTANCES OF THE OPIUM ROW N.A. Bokhan1, A.V. Semke1, A.P. Sidenkova2, A.F. Abolonin1 1 Mental Health Research Institute SB RAMSci, Tomsk, Russia. 2 Ural State Medical University, Yekaterinburg, Russia.
TOXIC PSYCHOSIS VS DUAL PATHOLOGY: LONGITUDINAL EVALUATION OF PATIENTS ADMITTED TO THE PSYCHIATRY DEPARTMENT OF HOSPITAL GARCIA DE ORTA S. Coelho, A. Roberto, D. Sennfelt Hospital Garcia de Orta, Lisbon, Portugal.
ZIPRASIDONE VS. CLOZAPINE IN THE TREATMENT OF DUALLY DIAGNOSED (DD) PATIENTS WITH SCHIZOPHRENIA AND CANNABIS USE DISORDERS: A RANDOMIZED STUDY E. Gouzoulis-Mayfrank1,2, T. Schnell1,3 1 University Hospital of Cologne, Cologne, Germany. 2 LVR Clinics Cologne, Cologne, Germany. 3 Medical School Hamburg (MSH), Hamburg, Germany.
www.cipd2015.com Pág. 59
th Monday April 20 PRELIMINARY PROGRAM - UPDATED: 10/04/2015
TREATING PSYCHOTIC PATIENTS WITH AGONIST OPIOID THERAPY AND ATYPICAL ANTIPSYCHOTICS Maria Chiara Pieri Drug Addiction Unit Bologna, Italy.
GENDER DIFFERENCES IN RETENTION IN DUALLY DIAGNOSED ADULTS ATTENDING PRIVATE RESIDENTIAL TREATMENT IN THE U.S. Siobhan Morse Foundations Recovery Network, Brentwood, TN. USA.
PSYCHOLOGICAL, ENVIRONMENTAL OR PHYSICAL FACTORS, WHICH IS THE FIRST CAUSE OF TENDENCY TO ADDICTION? Seyed Jalal Mosavi Amiri1, Alireza Homayouni 2, Gholamali Nikpour3, Arsalan Khanmohammadi Otaghsara4 1 Medical Clinic of Dr. Mosavi, Amirkola, Iran. 2 College of psychology, Bandargaz Branch, Islamic Azad University, Bandargaz, Iran. 3 Allameh Tabatabaii University, Tehran, Iran. 4 College of psychology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran.
DOES DRUG-INDUCED PSYCHOSIS REALLY EXIST? Luis Alfonso Núñez Domínguez1, María García Nicolas2, Olga Arbeo Ruiz3 1 Centro Médico. España. 2 Centro Salud Mental Tudela. España. 3 Centro de Día Zuría. España.
www.cipd2015.com Pág. 60
PARALLEL ACTIVITIES Thursday, April 16th NIDA RESEARCH PROJECT MEETING: INTERNATIONAL LATINO RESEARCH PARTNERSHIP 09:00 – 18:00 By invitation only SEPD Meeting Room Margarita Alegría, Center for Multicultural Mental Health Research, Cambridge Health Alliance & Harvard Medical School, Somerville. MA, USA. Friday, April 17th Enrique Baca, Fundación Jiménez Díaz, Madrid, España. 09:00 – 16:00 Francisco Collazos, Hospital Universitari Vall d'Hebron, Barcelona, España. SEPD Meeting Room Sociedad Española de Patología Dual SEPD
FOUNDATION ACTIVITIES Friday, April 17th DUAL PATHOLOGY AND ART 16:45 – 17:30 Co-organized by the Foundation on Dual Disorders Room 11 Chair: Lara Grau-López, Hospital Universitari Vall d’Hebron. Barcelona, España. Speaker: J. Ramon Pigem, Clínica Bellavista, Lleida, España.
Friday, April 17th Foundation on Dual Disorders 16:00 – 18:00 FEAFES Room 13 CROSSROADS OF DUAL PATHOLOGY: THE VISION OF ASSOCIATIONS OF PEOPLE WITH MENTAL ILLNESS AND THEIR FAMILIES Chairs: Pablo Vega, Sociedad Española de Patología Dual (SEPD); Instituto de Adicciones. Madrid, España. Nel Anxelu González, Confederación Española de Agrupaciones de Familiares y Personas con Enfermedad Mental (FEAFES), España. Speakers: José Mª Vázquez, CAS de Sants, Barcelona, España. Lina Mª Huertas, Confederación FEAFES, España. Rosario Tomás, CRIS de la asociación AFEPVI, Villena, Alicante, España. David Soriano, CRIS de la asociación AFEPVI, Villena, Alicante, España.
Friday, April 17th, SURVEY ON USE OF TOBACCO ON PROFESSIONALS Saturday, April 18th Sponsored by the Foundation on Dual Disorders Coordinated by: Fernando W. Müller, Centro de Investigaciones Clínicas WM. Argentina. Debora Serebrisky, Centro de Investigaciones Clínicas WM. Argentina. Diana Romero, Hospital Universitario Vall d'Hebron. SEPD. España. Alfonso Abad, Hospital Universitario Vall d'Hebron. SEPD. España.
Saturday, April 18th PROMOTION OF THE RESEARCH NETWORKS WITH CLINICAL AND PREVENTIVE 14:00 – 16:00 APPLICATION. ACTION 29 OF THE PND SEPD Meeting Room By invitation only
www.cipd2015.com Pág. 61
Chair: Francisco J. Álvarez, Instituto de Estudios de Alcohol y Drogas, Universidad de Valladolid, España. Speakers: José Oñorbe, Delegación del Gobierno del Plan Nacional sobre Drogas, Madrid, España. Rocío Molina, Centro de Atención a las Drogodependencias de Arganzuela. Madrid, España. María Estrada, Subdirecció General de Drogodependències, Barcelona, España.
Saturday, April 18th Medical Educational Room Room 9 Sponsored by the Foundation on Dual Disorders
Language: English 08:30 – 09:10 INFORMATION FOR PATIENTS ON INTERNET: QUALITY RESOURCES AND BLOG CREATION 09:15 – 09:55 PUBMED – ALERTS ZOTERO. CITATION MANAGEMENT SOFTWARE 14:00 – 14:40
Language: Spanish 14:45 – 15:25 PUBMED – ALERTAS 15:30 – 16:10 ZOTERO. GESTOR DE REFERENCIAS BIBLIOGRÁFICAS 16:15 – 16:55 INFORMACIÓN PARA PACIENTES EN INTERNET: RECURSOS DE CALIDAD Y CREACIÓN DE BLOGS
Sunday, April 19th Room 9
09:15 – 09:55 Language: English INFORMATION FOR PATIENTS ON INTERNET: QUALITY RESOURCES AND BLOG CREATION
Language: Spanish 12:00 – 12:40 PUBMED – ALERTAS 12:45 – 13:25 PUBMED – FILTROS PERSONALIZADOS 13:30 – 14:10 ZOTERO. GESTOR DE REFERENCIAS BIBLIOGRÁFICAS
Language: English 14:15 – 14:55 PUBMED – ALERTS 15:00 – 15:40 ZOTERO. CITATION MANAGEMENT SOFTWARE
Language: Spanish 15:45 – 16:25 INFORMACIÓN PARA PACIENTES EN INTERNET: RECURSOS DE CALIDAD Y CREACIÓN DE BLOGS
www.cipd2015.com Pág. 62